Davies NWS; Brew BJ, 2014, 'Clinical Aspects of HIV-Related Neurocognitive Disorders', in HIV and Psychiatry, pp. 107 - 156, http://dx.doi.org/10.1002/9781118339503.ch3

Cruse B; Brew BJ, 2014, 'Excitotoxicity in HIV associated neurocognitive disorders', in Handbook of Neurotoxicity, pp. 1247 - 1265, http://dx.doi.org/10.1007/978-1-4614-5836-4_143

Davies NWS; Brew BJ, 2011, 'Dizziness in someone with HIV', in Case Studies in Dementia: Common and Uncommon Presentations, pp. 180 - 187, http://dx.doi.org/10.1017/CBO9780511997433.026

Davies NP; Brew BJ, 2011, 'The pathobiology of HIV related neuropathies', in Gendelman HE (ed.), Cognitive Neurology: a clinical textbook, edn. 3rd edition, Oxford University Press, Oxford

Brew BJ, 2009, 'Global Issues in Neuro-AIDS and Their Evolution over the Future of the HAART Era', in Goodkin K; Shapshak P; Verma A (ed.), SPECTRUM OF NEURO-AIDS DISORDERS: PATHOPHYSIOLOGY, DIAGNOSIS, AND TREATMENT, AMER SOC MICROBIOLOGY, pp. 507 - 523, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000279006800037&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Gisslen M; Hagberg L; Cinque P; Brew B; Price RW, 2009, 'Cerebrospinal Fluid Markers in the Management of Central Nervous System HIV Infection and the AIDS Dementia Complex', in Goodkin K; Shapshak P; Verma A (ed.), SPECTRUM OF NEURO-AIDS DISORDERS: PATHOPHYSIOLOGY, DIAGNOSIS, AND TREATMENT, AMER SOC MICROBIOLOGY, pp. 173 - 179, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000279006800014&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Cysique LA; Brew BJ, 2009, 'The assessment of HIV-associated neurocognitive disorders: New challenges in the HAART era', in Paul R; Sacktor N; Valcour V; Tashima K (ed.), HIV and the Brain: New Challenges in the Modern Era, edn. 1st, Humana Press Inc, Totowa, pp. 109 - 132

Paul R; Sacktor N; Cysique LA; Brew BJ; Valcour V, 2009, 'Impact of clade diversity on neuropsychological outcomes', in Paul R; Sacktor N; Valcour V; Tashima K (ed.), HIV and the Brain: New Challenges in the Modern Era, edn. 1st, Humana Press Inc, Totowa, pp. 319 - 330

Brew BJ; Letendre S, 2009, 'Biomarkers of HIV-Related Central Nervous System Disease', in HIV and the Brain, Humana Press, pp. 49 - 73, http://dx.doi.org/10.1007/978-1-59745-434-6_5

Loy CT; Tomlinson S; Brew BJ, 2005, 'HIV-related neurological disease in the era of HAART', in Emerging Neurological Infections, pp. 427 - 452

Brew BJ, 2002, 'Neurological manaifestations of HIV Infection', in Crowe S; Hoy J; Mills J (ed.), Management of the HIV-infected Patient (2nd Ed), edn. Original, Martin Dunitz, London, UK, pp. 161 - 182

Brew BJ, 1996, 'Neurologic manifestations of HIV infection', in Management of the HIV-infected Patient, edn. Original, Cambridge University Press, Cambridge, pp. 109 - 124

Brew BJ, 1996, 'Neurological manifestations of HIV infection', in Management of the HIV-infected Patient, edn. Original, Cambridge University Press, Cambridge, pp. 109 - 124

Orr CF; Brew BJ, 'Chronic HIV infection of the CNS', in Inflammatory Diseases of the Central Nervous System, Cambridge University Press, pp. 137 - 160, http://dx.doi.org/10.1017/cbo9781139195805.012

Darley DR; Dore GJ; Byrne AL; Plit ML; Brew BJ; Kelleher A; Matthews GV, 2021, 'Limited recovery from post-acute sequelae of sars-cov-2 at 8 months in a prospective cohort', ERJ Open Research, vol. 7, pp. 00384 - 2021, http://dx.doi.org/10.1183/23120541.00384-2021

Clarke L; Arnett S; Bukhari W; Khalilidehkordi E; Jimenez Sanchez S; O'Gorman C; Sun J; Prain KM; Woodhall M; Silvestrini R; Bundell CS; Abernethy DA; Bhuta S; Blum S; Boggild M; Boundy K; Brew BJ; Brownlee W; Butzkueven H; Carroll WM; Chen C; Coulthard A; Dale RC; Das C; Fabis-Pedrini MJ; Gillis D; Hawke S; Heard R; Henderson APD; Heshmat S; Hodgkinson S; Kilpatrick TJ; King J; Kneebone C; Kornberg AJ; Lechner-Scott J; Lin MW; Lynch C; Macdonell RAL; Mason DF; McCombe PA; Pereira J; Pollard JD; Ramanathan S; Reddel SW; Shaw CP; Spies JM; Stankovich J; Sutton I; Vucic S; Walsh M; Wong RC; Yiu EM; Barnett MH; Kermode AGK; Marriott MP; Parratt JDE; Slee M; Taylor BV; Willoughby E; Brilot F; Vincent A; Waters P; Broadley SA, 2021, 'MRI Patterns Distinguish AQP4 Antibody Positive Neuromyelitis Optica Spectrum Disorder From Multiple Sclerosis', Frontiers in Neurology, vol. 12, http://dx.doi.org/10.3389/fneur.2021.722237

Brouillette MJ; Koski L; Forcellino L; Gasparri J; Brew BJ; Fellows LK; Mayo NE; Cysique LA, 2021, 'Predicting occupational outcomes from neuropsychological test performance in older people with HIV', AIDS (London, England), vol. 35, pp. 1765 - 1774, http://dx.doi.org/10.1097/QAD.0000000000002927

Gates TM; Kamminga J; Jayewardene A; Vincent T; Quan D; Brew BJ; Bloch M; Cysique LA, 2021, 'Erratum: An examination of reliable change methods for measuring cognitive change with the cogstate computerized battery: Research and clinical implications (Archives of Clinical Neuropsychology (2021) DOI: 10.1093/arclin/acaa076)', Archives of Clinical Neuropsychology, vol. 36, pp. 859, http://dx.doi.org/10.1093/arclin/acaa127

Gates TM; Kamminga J; Jayewardene A; Vincent T; Quan D; Brew BJ; Bloch M; Cysique LA, 2021, 'An examination of reliable change methods for measuring cognitive change with the Cogstate Computerized Battery: Research and clinical implications', Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists, vol. 36, pp. 597 - 612, http://dx.doi.org/10.1093/arclin/acaa076

Brew BJ; Faux S; Blanchard E, 2021, 'Efficacy of a smartwatch application in detecting induced falls (Preprint)', JMIR Formative Research, http://dx.doi.org/10.2196/30121

Chaganti J; Woodford H; Tomlinson S; Dunkerton S; Brew B, 2021, 'Black blood imaging of intracranial vessel walls', Practical Neurology, vol. 21, pp. 101 - 107, http://dx.doi.org/10.1136/practneurol-2020-002806

Darley D; Matthews G; Dore G; Wilhelm K; Plit M; Stone E; Byrne A; Tonga K; Andresen D; Kelleher A; Cysique L; Cunningham P; Brew B, 2021, 'Persistent symptoms up to four months after community and hospital- managed SARS- CoV- 2 infection', Medical Journal of Australia, http://dx.doi.org/10.5694/mja2.50963

Aung HL; Aghvinian M; Gouse H; Robbins RN; Brew BJ; Mao L; Cysique LA, 2021, 'Is There Any Evidence of Premature, Accentuated and Accelerated Aging Effects on Neurocognition in People Living with HIV? A Systematic Review', AIDS and Behavior, vol. 25, pp. 917 - 960, http://dx.doi.org/10.1007/s10461-020-03053-3

Aung HL; Bloch M; Vincent T; Quan D; Jayewardene A; Liu Z; Gates TM; Brew B; Mao L; Cysique LA, 2021, 'Cognitive ageing is premature among a community sample of optimally treated people living with HIV', HIV Medicine, vol. 22, pp. 151 - 164, http://dx.doi.org/10.1111/hiv.12980

Vance DE; Brew BJ, 2021, 'HIV neurocognitive impairment and Alzheimer’s disease: Sniffing out the difference', AIDS, vol. 35, pp. 511 - 513, http://dx.doi.org/10.1097/QAD.0000000000002731

Nir TM; Fouche JP; Ananworanich J; Ances BM; Boban J; Brew BJ; Chaganti JR; Chang L; Ching CRK; Cysique LA; Ernst T; Faskowitz J; Gupta V; Harezlak J; Heaps-Woodruff JM; Hinkin CH; Hoare J; Joska JA; Kallianpur KJ; Kuhn T; Lam HY; Law M; Lebrun-Frénay C; Levine AJ; Mondot L; Nakamoto BK; Navia BA; Pennec X; Porges EC; Salminen LE; Shikuma CM; Surento W; Thames AD; Valcour V; Vassallo M; Woods AJ; Thompson PM; Cohen RA; Paul R; Stein DJ; Jahanshad N, 2021, 'Association of Immunosuppression and Viral Load with Subcortical Brain Volume in an International Sample of People Living with HIV', JAMA Network Open, vol. 4, pp. e2031190, http://dx.doi.org/10.1001/jamanetworkopen.2020.31190

Angelovich TA; Churchill MJ; Wright EJ; Brew BJ, 2021, 'New Potential Axes of HIV Neuropathogenesis with Relevance to Biomarkers and Treatment', Curr Top Behav Neurosci, vol. 50, pp. 3 - 39, http://dx.doi.org/10.1007/7854_2019_126

Braidy N; Alicajic H; Pow D; Smith J; Jugder BE; Brew BJ; Nicolazzo JA; Guillemin GJ, 2021, 'Potential Mechanism of Cellular Uptake of the Excitotoxin Quinolinic Acid in Primary Human Neurons', Molecular Neurobiology, vol. 58, pp. 34 - 54, http://dx.doi.org/10.1007/s12035-020-02046-6

Bukhari W; Khalilidehkordi E; Mason DF; Barnett MH; Taylor BV; Fabis-Pedrini M; Kermode AG; Subramanian S; Waters P; Broadley SA; Broadley SA; Abernethy D; Bhuta S; Blum S; Boggild M; Boundy K; Brew BJ; Brilot F; Brownlee WJ; Bundell CS; Butzkueven H; Carroll WM; Chen C; Clarke L; Coulthard A; Dale RC; Das C; Dear K; Fulcher D; Gillis D; Hawke S; Heard R; Henderson APD; Heshmat S; Hodgkinson S; Jimenez Sanchez S; Kilpatrick TJ; King J; Kneebone C; Kornberg AJ; Lechner-Scott J; Lin MW; Lynch C; Macdonell RAL; Marriott MP; McCombe PA; O’Gorman C; Parratt JDE; Pender MP; Pereira J; Pollard JD; Prain KM; Ramanathan S; Reddell SW; Shaw C; Silvestrini RA; Slee M; Spies J; Stankovich J; Sutton I; Vincent A; Vucic S; Walsh M; Willoughby E; Wong RC; Woodhall M; Yiu EM, 2021, 'NMOSD and MS prevalence in the Indigenous populations of Australia and New Zealand', Journal of Neurology, http://dx.doi.org/10.1007/s00415-021-10665-9

Caffrey Osvald E; Bower H; Lundholm C; Larsson H; Brew BK; Almqvist C, 2020, 'Asthma and all-cause mortality in children and young adults: A population-based study', Thorax, vol. 75, pp. 1040 - 1046, http://dx.doi.org/10.1136/thoraxjnl-2020-214655

Calon M; Menon K; Carr A; Henry RG; Rae CD; Brew BJ; Cysique LA, 2020, 'Additive and Synergistic Cardiovascular Disease Risk Factors and HIV Disease Markers' Effects on White Matter Microstructure in Virally Suppressed HIV', Journal of Acquired Immune Deficiency Syndromes, vol. 84, pp. 543 - 551, http://dx.doi.org/10.1097/QAI.0000000000002390

Howdle GC; Quidé Y; Kassem MS; Johnson K; Rae CD; Brew BJ; Cysique LA, 2020, 'Brain amyloid in virally suppressed HIV-associated neurocognitive disorder', Neurology(R) neuroimmunology & neuroinflammation, vol. 7, http://dx.doi.org/10.1212/NXI.0000000000000739

Khalilidehkordi E; Clarke L; Arnett S; Bukhari W; Jimenez Sanchez S; O'Gorman C; Sun J; Prain KM; Woodhall M; Silvestrini R; Bundell CS; Abernethy D; Bhuta S; Blum S; Boggild M; Boundy K; Brew BJ; Brown M; Brownlee W; Butzkueven H; Carroll WM; Chen C; Coulthard A; Dale RC; Das C; Fabis-Pedrini MJ; Fulcher D; Gillis D; Hawke S; Heard R; Henderson APD; Heshmat S; Hodgkinson S; Kilpatrick TJ; King J; Kneebone C; Kornberg AJ; Lechner-Scott J; Lin MW; Lynch C; Macdonell RAL; Mason DF; McCombe PA; Pereira J; Pollard JD; Ramanathan S; Reddel SW; Shaw C; Spies J; Stankovich J; Sutton I; Vucic S; Walsh M; Wong RC; Yiu EM; Barnett MH; Kermode AG; Marriott MP; Parratt J; Slee M; Taylor BV; Willoughby E; Brilot F; Vincent A; Waters P; Broadley SA, 2020, 'Relapse Patterns in NMOSD: Evidence for Earlier Occurrence of Optic Neuritis and Possible Seasonal Variation', Frontiers in Neurology, vol. 11, http://dx.doi.org/10.3389/fneur.2020.00537

Sundaram G; Lim CK; Brew BJ; Guillemin GJ, 2020, 'Kynurenine pathway modulation reverses the experimental autoimmune encephalomyelitis mouse disease progression', Journal of Neuroinflammation, vol. 17, pp. 176, http://dx.doi.org/10.1186/s12974-020-01844-y

Bukhari W; Clarke L; O’Gorman C; Khalilidehkordi E; Arnett S; Prain KM; Woodhall M; Silvestrini R; Bundell CS; Ramanathan S; Abernethy D; Bhuta S; Blum S; Boggild M; Boundy K; Brew BJ; Brownlee W; Butzkueven H; Carroll WM; Chen C; Coulthard A; Dale RC; Das C; Dear K; Fabis-Pedrini MJ; Fulcher D; Gillis D; Hawke S; Heard R; Henderson APD; Heshmat S; Hodgkinson S; Jimenez-Sanchez S; Kilpatrick TJ; King J; Kneebone C; Kornberg AJ; Lechner-Scott J; Lin MW; Lynch C; Macdonnell RAL; Mason DF; McCombe PA; Pereira J; Pollard JD; Reddel SW; Shaw C; Spies J; Stankovich J; Sutton I; Vucic S; Walsh M; Wong RC; Yiu EM; Barnett MH; Kermode AG; Marriott MP; Parratt J; Slee M; Taylor BV; Willoughby E; Wilson RJ; Brilot F; Vincent A; Waters P; Broadley SA, 2020, 'The clinical profile of NMOSD in Australia and New Zealand', Journal of Neurology, vol. 267, pp. 1431 - 1443, http://dx.doi.org/10.1007/s00415-020-09716-4

Zeng G; Penninkilampi R; Chaganti J; Montagnese S; Brew BJ; Danta M, 2020, 'Meta-analysis of magnetic resonance spectroscopy in the diagnosis of hepatic encephalopathy', Neurology, vol. 94, pp. e1147 - e1156, http://dx.doi.org/10.1212/WNL.0000000000008899

Brew BJ; McArthur JC, 2020, ''A man is as old as his arteries' (attributed to Thomas Sydenham, the English Hippocrates)', AIDS, vol. 34, pp. 637 - 639, http://dx.doi.org/10.1097/QAD.0000000000002414

Tun N; Chaganti J; Zeng G; Lockart I; Montagnese S; Brew B; Danta M, 2020, 'Prospective study of magnetic resonance spectroscopy identifies specific metabolic changes in covert hepatic encephalopathy', Journal of Hepatology, vol. 73, pp. S737 - S737, http://dx.doi.org/10.1016/s0168-8278(20)31924-3

Situ Y; Subbiah R; Brew B; Holloway C, 2020, '243 Pilot Study of the Samsung S-patch for Cardiac Monitoring', Heart, Lung and Circulation, vol. 29, pp. S143 - S143, http://dx.doi.org/10.1016/j.hlc.2020.09.250

Brew BJ; Barnes SL, 2019, 'The impact of HIV central nervous system persistence on pathogenesis', AIDS, vol. 33, pp. S113 - S121, http://dx.doi.org/10.1097/QAD.0000000000002251

Zhai S; McColl C; Mahajan A; Lueck CJ; Brew BJ, 2019, 'Recurrent HIV-associated posterior reversible encephalopathy syndrome', Neurology: Clinical Practice, vol. 9, pp. 478 - 480, http://dx.doi.org/10.1212/CPJ.0000000000000602

Barnes SL; Brew BJ, 2019, 'Acute cerebellar ataxia after Epstein-Barr virus infection', Neurology: Clinical Practice, vol. 9, pp. 505 - 506, http://dx.doi.org/10.1212/CPJ.0000000000000659

Cysique LA; Brew BJ, 2019, 'Vascular cognitive impairment and HIV-associated neurocognitive disorder: a new paradigm', Journal of NeuroVirology, vol. 25, pp. 710 - 721, http://dx.doi.org/10.1007/s13365-018-0706-5

Chaganti J; Marripudi K; Staub LP; Rae CD; Gates TM; Moffat KJ; Brew BJ, 2019, 'Imaging correlates of the blood-brain barrier disruption in HIV-associated neurocognitive disorder and therapeutic implications', AIDS, vol. 33, pp. 1843 - 1852, http://dx.doi.org/10.1097/QAD.0000000000002300

Brew BJ; McArthur J, 2019, 'Distinguishing cognitive impairment from HIV-associated neurocognitive disorder versus substance use?', AIDS, vol. 33, pp. 1943 - 1944, http://dx.doi.org/10.1097/QAD.0000000000002292

Brew BJ; Paul R, 2019, 'HIV-associated neurocognitive disorder, extracellular vesicles and gender: Vive la difference?', AIDS, vol. 33, pp. 1795 - 1796, http://dx.doi.org/10.1097/QAD.0000000000002273

Jacobs KR; Lim CK; Blennow K; Zetterberg H; Chatterjee P; Martins RN; Brew BJ; Guillemin GJ; Lovejoy DB, 2019, 'Correlation between plasma and CSF concentrations of kynurenine pathway metabolites in Alzheimer's disease and relationship to amyloid-β and tau', Neurobiology of Aging, vol. 80, pp. 11 - 20, http://dx.doi.org/10.1016/j.neurobiolaging.2019.03.015

Aung HL; Kootar S; Gates TM; Brew BJ; Cysique LA, 2019, 'How all-type dementia risk factors and modifiable risk interventions may be relevant to the first-generation aging with HIV infection?', European Geriatric Medicine, vol. 10, pp. 227 - 238, http://dx.doi.org/10.1007/s41999-019-00164-6

Cysique LA; Jugé L; Lennon MJ; Gates TM; Jones SP; Lovelace MD; Rae CD; Johnson TP; Nath A; Brew BJ, 2019, 'HIV brain latency as measured by CSF BcL11b relates to disrupted brain cellular energy in virally suppressed HIV infection', AIDS, vol. 33, pp. 433 - 441, http://dx.doi.org/10.1097/QAD.0000000000002076

Cysique LA; Brew BJ, 2019, 'Comorbid depression and apathy in HIV-associated neurocognitive disorders in the era of chronic HIV infection', , vol. 165, pp. 71 - 82, http://dx.doi.org/10.1016/B978-0-444-64012-3.00006-X

Asahchop EL; Branton WG; Krishnan A; Chen PA; Yang D; Kong L; Zochodne DW; Brew BJ; Gill MJ; Power C, 2018, 'HIV-associated sensory polyneuropathy and neuronal injury are associated with miRNA-455-3p induction', JCI insight, vol. 3, http://dx.doi.org/10.1172/jci.insight.122450

Sutherland EJ; Brew BJ, 2018, 'Human Immunodeficiency Virus and the Nervous System', Neurologic Clinics, vol. 36, pp. 751 - 765, http://dx.doi.org/10.1016/j.ncl.2018.07.002

Nichols M; Gates T; Soares J; Moffat K; Rae C; Brew B; Cysique L, 2018, 'Brain atrophic signatures of mild forms of neurocognitive impairment in virally suppressed HIV infection', AIDS, vol. 33, pp. 55 - 66, http://dx.doi.org/10.1097/QAD.0000000000002042

Wilson MR; O'Donovan BD; Gelfand JM; Sample HA; Chow FC; Betjemann JP; Shah MP; Richie MB; Gorman MP; Hajj-Ali RA; Calabrese LH; Zorn KC; Chow ED; Greenlee JE; Blum JH; Green G; Khan LM; Banerji D; Langelier C; Bryson-Cahn C; Harrington W; Lingappa JR; Shanbhag NM; Green AJ; Brew BJ; Soldatos A; Strnad L; Doernberg SB; Jay CA; Douglas V; Josephson SA; DeRisi JL, 2018, 'Chronic meningitis investigated via metagenomic next-generation sequencing', JAMA Neurology, vol. 75, pp. 947 - 955, http://dx.doi.org/10.1001/jamaneurol.2018.0463

Anderson AM; Croteau D; Ellis RJ; Rosario D; Potter M; Guillemin GJ; Brew BJ; Woods SP; Letendre SL, 2018, 'HIV, prospective memory, and cerebrospinal fluid concentrations of quinolinic acid and phosphorylated Tau', Journal of Neuroimmunology, vol. 319, pp. 13 - 18, http://dx.doi.org/10.1016/j.jneuroim.2018.03.007

Wright EJ; Grund B; Robertson KR; Cysique L; Brew BJ; Collins GL; Poehlman-Roediger M; Vjecha MJ; Penalva De Oliveira AC; Standridge B; Carey C; Avihingsanon A; Florence E; Lundgren JD; Arenas-Pinto A; Mueller NJ; Winston A; Nsubuga MS; Lal L; Price RW, 2018, 'No neurocognitive advantage for immediate antiretroviral treatment in adults with greater than 500 CD4⁺ T-cell counts', AIDS, vol. 32, pp. 985 - 997, http://dx.doi.org/10.1097/QAD.0000000000001778

Haggstrom L; Brew B; Sutton I; Tisch S, 2018, 'Vestibular symptoms as the presenting feature of progressive supranuclear palsy', Journal of Clinical Neuroscience, vol. 50, pp. 74 - 76, http://dx.doi.org/10.1016/j.jocn.2018.01.021

Bundell C; Brunt SJ; Cysique LA; Brusch A; Brew BJ; Price P, 2018, 'The high frequency of autoantibodies in HIV patients declines on antiretroviral therapy', Pathology, vol. 50, pp. 313 - 316, http://dx.doi.org/10.1016/j.pathol.2017.10.017

Warhurst S; Rofe CJ; Brew BJ; Bateson D; McGeechan K; Merki-Feld GS; Garrick R; Tomlinson SE, 2018, 'Effectiveness of the progestin-only pill for migraine treatment in women: A systematic review and meta-analysis', Cephalalgia, vol. 38, pp. 754 - 764, http://dx.doi.org/10.1177/0333102417710636

Brew BJ; Garber JY, 2018, 'Neurologic sequelae of primary HIV infection', Handbook of Clinical Neurology, vol. 152, pp. 65 - 74, http://dx.doi.org/10.1016/B978-0-444-63849-6.00006-2

Radd-Vagenas S; Duffy SL; Naismith SL; Brew BJ; Flood VM; Fiatarone Singh MA, 2018, 'Effect of the Mediterranean diet on cognition and brain morphology and function: A systematic review of randomized controlled trials', American Journal of Clinical Nutrition, vol. 107, pp. 389 - 404, http://dx.doi.org/10.1093/ajcn/nqx070

Cysique LA; Jugé L; Gates T; Tobia M; Moffat K; Brew BJ; Rae C, 2018, 'Covertly active and progressing neurochemical abnormalities in suppressed HIV infection', Neurology: Neuroimmunology and NeuroInflammation, vol. 5, http://dx.doi.org/10.1212/NXI.0000000000000430

Zhai S; Brew BJ, 2018, 'Progressive multifocal leukoencephalopathy', Handbook of Clinical Neurology, vol. 152, pp. 123 - 137, http://dx.doi.org/10.1016/B978-0-444-63849-6.00010-4

Brew BJ, 2018, 'Introduction to HIV infection and HIV neurology', Handbook of Clinical Neurology, vol. 152, pp. 1 - 2, http://dx.doi.org/10.1016/B978-0-444-63849-6.00001-3

Smail RC; Brew BJ, 2018, 'HIV-associated neurocognitive disorder', Handbook of Clinical Neurology, vol. 152, pp. 75 - 97, http://dx.doi.org/10.1016/B978-0-444-63849-6.00007-4

Kamminga J; Bloch M; Vincent T; Carberry A; Brew BJ; Cysique LA, 2017, 'Determining optimal impairment rating methodology for a new HIV-associated neurocognitive disorder screening procedure', Journal of Clinical and Experimental Neuropsychology, vol. 39, pp. 753 - 767, http://dx.doi.org/10.1080/13803395.2016.1263282

Brew BJ; Cysique L, 2017, 'Does HIV prematurely age the brain?', The Lancet HIV, vol. 4, pp. e380 - e381, http://dx.doi.org/10.1016/S2352-3018(17)30108-X

Cysique LA; Soares JR; Geng G; Scarpetta M; Moffat K; Green M; Brew BJ; Henry RG; Rae C, 2017, 'White matter measures are near normal in controlled HIV infection except in those with cognitive impairment and longer HIV duration', Journal of NeuroVirology, vol. 23, pp. 539 - 547, http://dx.doi.org/10.1007/s13365-017-0524-1

Bukhari W; Prain KM; Waters P; Woodhall M; O'Gorman CM; Clarke L; Silvestrini RA; Bundell CS; Abernethy D; Bhuta S; Blum S; Boggild M; Boundy K; Brew BJ; Brown M; Brownlee WJ; Butzkueven H; Carroll WM; Chen C; Coulthard A; Dale RC; Das C; Dear K; Fabis-Pedrini MJ; Fulcher D; Gillis D; Hawke S; Heard R; Henderson APD; Heshmat S; Hodgkinson S; Jimenez-Sanchez S; Killpatrick T; King J; Kneebone C; Kornberg AJ; Lechner-Scott J; Lin MW; Lynch C; Macdonell R; Mason DF; McCombe PA; Pender MP; Pereira JA; Pollard JD; Reddel SW; Shaw C; Spies J; Stankovich J; Sutton I; Vucic S; Walsh M; Wong RC; Yiu EM; Barnett MH; Kermode AG; Marriott MP; Parratt JDE; Slee M; Taylor BV; Willoughby E; Wilson RJ; Vincent A; Broadley SA, 2017, 'Incidence and prevalence of NMOSD in Australia and New Zealand', Journal of Neurology, Neurosurgery and Psychiatry, vol. 88, pp. 632 - 638, http://dx.doi.org/10.1136/jnnp-2016-314839

Cysique LA; Soares JR; Geng G; Scarpetta M; Moffat K; Green M; Brew BJ; Henry RG; Rae C, 2017, 'Erratum to: White matter measures are near normal in controlled HIV infection except in those with cognitive impairment and longer HIV duration (Journal of NeuroVirology, (2017), 23, 4, (539-547), 10.1007/s13365-017-0524-1)', Journal of NeuroVirology, vol. 23, pp. 548 - 549, http://dx.doi.org/10.1007/s13365-017-0542-z

Chaganti JR; Heinecke A; Gates TM; Moffat KJ; Brew BJ, 2017, 'Functional connectivity in virally suppressed patients with HIV-associated neurocognitive disorder: A resting-state analysis', American Journal of Neuroradiology, vol. 38, pp. 1623 - 1629, http://dx.doi.org/10.3174/ajnr.A5246

Kamminga J; Lal L; Wright EJ; Bloch M; Brew BJ; Cysique LA, 2017, 'Monitoring HIV-Associated Neurocognitive Disorder Using Screenings: a Critical Review Including Guidelines for Clinical and Research Use', Current HIV/AIDS Reports, vol. 14, pp. 83 - 92, http://dx.doi.org/10.1007/s11904-017-0349-9

Lennon MJ; Jones SP; Lovelace MD; Guillemin GJ; Brew BJ, 2017, 'Bcl11b-A critical neurodevelopmental transcription factor-roles in health and disease', Frontiers in Cellular Neuroscience, vol. 11, http://dx.doi.org/10.3389/fncel.2017.00089

Gott C; Gates T; Dermody N; Brew BJ; Cysique LA, 2017, 'Cognitive change trajectories in virally suppressed HIV-infected individuals indicate high prevalence of disease activity', PLOS ONE, vol. 12, http://dx.doi.org/10.1371/journal.pone.0171887

Lim CK; Bilgin A; Lovejoy DB; Tan V; Bustamante S; Taylor BV; Bessede A; Brew BJ; Guillemin GJ, 2017, 'Kynurenine pathway metabolomics predicts and provides mechanistic insight into multiple sclerosis progression', Scientific Reports, vol. 7, http://dx.doi.org/10.1038/srep41473

Ellero J; Lubomski M; Brew B, 2017, 'Interventions for Neurocognitive Dysfunction', Current HIV/AIDS Reports, vol. 14, pp. 8 - 16, http://dx.doi.org/10.1007/s11904-017-0346-z

Cysique LA; Gott C; Gates TM; Dermody N; Brew BJ, 2017, 'Cognitive Change Trajectories in Virally Suppressed HIV-Infected Individuals Indicate High Prevalence of Disease Activity', PLoS One, vol. 12, http://dx.doi.org/10.1371/journal.pone.0171887

Lovelace MD; Varney B; Sundaram G; Lennon MJ; Lim CK; Jacobs K; Guillemin GJ; Brew BJ, 2017, 'Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases', Neuropharmacology, vol. 112, pp. 373 - 388, http://dx.doi.org/10.1016/j.neuropharm.2016.03.024

Lee JM; Tan V; Lovejoy D; Braidy N; Rowe DB; Brew BJ; Guillemin GJ, 2017, 'Involvement of quinolinic acid in the neuropathogenesis of amyotrophic lateral sclerosis', Neuropharmacology, vol. 112, pp. 346 - 364, http://dx.doi.org/10.1016/j.neuropharm.2016.05.011

Brew B; Carroll A, 2017, 'HIV-associated neurocognitive disorders: Recent advances in pathogenesis, biomarkers, and treatment', F1000Research, vol. 6, http://dx.doi.org/10.12688/f1000research.10651.1

Anesten B; Yilmaz A; Hagberg L; Zetterberg H; Nilsson S; Brew BJ; Fuchs D; Price RW; Gisslén M, 2016, 'Blood-brain barrier integrity, intrathecal immunoactivation, and neuronal injury in HIV', Neurology: Neuroimmunology and NeuroInflammation, vol. 3, http://dx.doi.org/10.1212/NXI.0000000000000300

Braidy N; Rossez H; Lim CK; Jugder BE; Brew BJ; Guillemin GJ, 2016, 'Characterization of the Kynurenine Pathway in CD8⁺ Human Primary Monocyte-Derived Dendritic Cells', Neurotoxicity Research, vol. 30, pp. 620 - 632, http://dx.doi.org/10.1007/s12640-016-9657-x

Tobia M; Jones S; Lovelace M; Rae C; Cysique L; Brew B, 2016, 'Reduced cellular energy as a potential marker of HIV brain latency related neuropathogenesis: a pilot study', JOURNAL OF NEUROVIROLOGY, vol. 22, pp. S76 - S77, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000394093700158&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Brew BJ, 2016, 'Has HIV-associated neurocognitive disorders now transformed into vascular cognitive impairment?', AIDS, vol. 30, pp. 2379 - 2380, http://dx.doi.org/10.1097/QAD.0000000000001225

Walker S; Brew B, 2016, 'Kaposi sarcoma in a fingolimod-treated patient with multiple sclerosis', Journal of Clinical Neuroscience, vol. 31, pp. 217 - 218, http://dx.doi.org/10.1016/j.jocn.2016.03.001

Nadel J; O'Dwyer E; Emmanuel S; Huang J; Cheruvu S; Sammel N; Brew B; Otton J; Holloway CJ, 2016, 'High-risk coronary plaque, invasive coronary procedures, and cardiac events among HIV-positive individuals and matched controls', Journal of Cardiovascular Computed Tomography, vol. 10, pp. 391 - 397, http://dx.doi.org/10.1016/j.jcct.2016.07.018

Bloch M; Kamminga J; Jayewardene A; Bailey M; Carberry A; Vincent T; Quan D; Maruff P; Brew B; Cysique LA, 2016, 'A Screening Strategy for HIV-Associated Neurocognitive Disorders That Accurately Identifies Patients Requiring Neurological Review', Clinical Infectious Diseases, vol. 63, pp. 687 - 693, http://dx.doi.org/10.1093/cid/ciw399

Lovelace MD; Varney B; Sundaram G; Franco NF; Ng ML; Pai S; Lim CK; Guillemin GJ; Brew BJ, 2016, 'Current evidence for a role of the kynurenine pathway of tryptophan metabolism in multiple sclerosis', Frontiers in Immunology, vol. 7, http://dx.doi.org/10.3389/fimmu.2016.00246

Crossley KM; Agnihotri S; Chaganti J; Rodriguez ML; McNally LP; Venna N; Turbett SE; Gutman M; Morey A; Koralnik IJ; Brew BJ, 2016, 'Recurrence of progressive multifocal leukoencephalopathy despite immune recovery in two HIV seropositive individuals', Journal of NeuroVirology, vol. 22, pp. 541 - 545, http://dx.doi.org/10.1007/s13365-015-0419-y

Gray LR; Brew BJ; Churchill MJ, 2016, 'Strategies to target HIV-1 in the central nervous system', Current Opinion in HIV and AIDS, vol. 11, pp. 371 - 375, http://dx.doi.org/10.1097/COH.0000000000000278

Brunt SJ; Cysique LA; Lee S; Burrows S; Brew BJ; Price P, 2016, 'Short communication: Do cytomegalovirus antibody levels associate with age-related syndromes in HIV patients stable on antiretroviral therapy?', AIDS Research and Human Retroviruses, vol. 32, pp. 567 - 572, http://dx.doi.org/10.1089/aid.2015.0328

Gray LR; Cowley D; Welsh C; Lu HK; Brew BJ; Lewin SR; Wesselingh SL; Gorry PR; Churchill MJ, 2016, 'CNS-specific regulatory elements in brain-derived HIV-1 strains affect responses to latency-reversing agents with implications for cure strategies', Molecular Psychiatry, vol. 21, pp. 574 - 584, http://dx.doi.org/10.1038/mp.2015.111

Gates TM; Cysique LA; Siefried KJ; Chaganti J; Moffat KJ; Brew BJ, 2016, 'Maraviroc-intensified combined antiretroviral therapy improves cognition in virally suppressed HIV-associated neurocognitive disorder', AIDS, vol. 30, pp. 591 - 600, http://dx.doi.org/10.1097/QAD.0000000000000951

Lennon MJ; Jones SP; Lovelace MD; Guillemin GJ; Brew BJ, 2016, 'Bcl11b: A New Piece to the Complex Puzzle of Amyotrophic Lateral Sclerosis Neuropathogenesis?', Neurotoxicity Research, vol. 29, pp. 201 - 207, http://dx.doi.org/10.1007/s12640-015-9573-5

Cysique LA; Dermody N; Carr A; Brew BJ; Teesson M, 2016, 'The role of depression chronicity and recurrence on neurocognitive dysfunctions in HIV-infected adults', Journal of NeuroVirology, vol. 22, pp. 56 - 65, http://dx.doi.org/10.1007/s13365-015-0368-5

Watts J; Brew B; Tisch S, 2015, 'Myasthenia gravis exacerbation with low dose ocular botulinum toxin for epiphoria', Journal of Clinical Neuroscience, vol. 22, pp. 1979 - 1981, http://dx.doi.org/10.1016/j.jocn.2015.05.032

Cysique LA; Dermody N; Carr A; Brew BJ; Teesson M, 2015, 'The role of depression chronicity and recurrence on neurocognitive dysfunctions in HIV-infected adults', Journal of NeuroVirology, vol. 22, pp. 56 - 65, http://dx.doi.org/10.1007/s13365-015-0368-5

Broadley SA; Barnett MH; Boggild M; Brew BJ; Butzkueven H; Heard R; Hodgkinson S; Kermode AG; Lechner-Scott J; Macdonell RA; Marriott M; Mason DF; Parratt J; Reddel SW; Shaw CP; Slee M; Spies JM; Taylor BV; Carroll WM; Kilpatrick TJ; King J; McCombe PA; Pollard JD; Willoughby E, 2015, 'A new era in the treatment of multiple sclerosis', Medical Journal of Australia, vol. 203, pp. 139 - 141, http://dx.doi.org/10.5694/mja14.01218

Jones SP; Franco NF; Varney B; Sundaram G; Brown DA; De Bie J; Lim CK; Guillemin GJ; Brew BJ, 2015, 'Expression of the kynurenine pathway in human peripheral blood mononuclear cells: Implications for inflammatory and neurodegenerative disease', PLoS ONE, vol. 10, http://dx.doi.org/10.1371/journal.pone.0131389

Brew BJ; Robertson K; Wright EJ; Churchill M; Crowe SM; Cysique LA; Deeks S; Garcia JV; Gelman B; Gray LR; Johnson T; Joseph J; Margolis DM; Mankowski JL; Spencer B, 2015, 'HIV eradication symposium: will the brain be left behind?', Journal of NeuroVirology, vol. 21, pp. 322 - 334, http://dx.doi.org/10.1007/s13365-015-0322-6

Britton PN; Eastwood K; Brew BJ; Nagree Y; Jones CA, 2015, 'Consensus guidelines for the investigation and management of encephalitis', Medical Journal of Australia, vol. 202, pp. 576 - 577, http://dx.doi.org/10.5694/mja14.01042

Fois AF; Brew BJ, 2015, 'The Potential of the CNS as a Reservoir for HIV-1 Infection: Implications for HIV Eradication', Current HIV/AIDS Reports, vol. 12, pp. 299 - 303, http://dx.doi.org/10.1007/s11904-015-0257-9

Britton PN; Eastwood K; Paterson B; Durrheim DN; Dale RC; Cheng AC; Kenedi C; Brew BJ; Burrow J; Nagree Y; Leman P; Smith DW; Read K; Booy R; Jones CA, 2015, 'Consensus guidelines for the investigation and management of encephalitis in adults and children in Australia and New Zealand', Internal Medicine Journal, vol. 45, pp. 563 - 576, http://dx.doi.org/10.1111/imj.12749

Cysique LA; Hey-Cunningham WJ; Dermody N; Chan P; Brew BJ; Koelsch KK, 2015, 'Peripheral blood mononuclear cells HIV DNA levels impact intermittently on neurocognition', PLoS ONE, vol. 10, http://dx.doi.org/10.1371/journal.pone.0120488

Wright EJ; Grund B; Cysique LA; Robertson KR; Brew BJ; Collins G; Shlay JC; Winston A; Read TRH; Price RW, 2015, 'Factors associated with neurocognitive test performance at baseline: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial', HIV MEDICINE, vol. 16, pp. 97 - 108, http://dx.doi.org/10.1111/hiv.12238

Cysique LA; Hewitt T; Croitoru-Lamoury J; Taddei K; Martins RN; Chew CSN; Davies NNWS; Price P; Brew BJ, 2015, 'APOE ε4 moderates abnormal CSF-abeta-42 levels, while neurocognitive impairment is associated with abnormal CSF tau levels in HIV+ individuals - A cross-sectional observational study', BMC Neurology, vol. 15, http://dx.doi.org/10.1186/s12883-015-0298-0

Lundgren J; Babiker A; Gordin F; Emery S; Fätkenheuer G; Molina JM; Wood R; Neaton JD; Agan BK; Alston-Smith B; Arenas-Pinto A; Arribas JR; Baker JV; Baxter J; Belloso WH; Brekke K; Brew B; Brobst SW; Burman W; Carey C; Clark R; Cooper DA; Davey RT; De La Rosa G; Denning ET; Dolan M; Dore G; Duprez D; Emanuel E; Grady C; Grund B; Hirschel B; Hoen B; Hudson F; Johnson MA; Kambili C; Klingman K; Kunisaki KM; Landay A; Ledergerber B; Lehrman SN; Martinez A; Meger S; Misar K; Mitsuyasu RT; Mocroft A; Munroe D; Norton M; Palmer RC; Pett SL; Phillips A; Pillay D; Porter D; Price RW; Proschan M; Rappoport C; Reiss P; Renjifo B; Robertson K; Rockstroh J; Rodriguez G; Rooney JF; Ross MJ; Schechter M; Schwarze S; Seekins D; Sharma S; Snowden W; Telenti A; Tryon J; van Wyk J; Vjecha MJ; Wright E, 2015, 'Why START? Reflections that led to the conduct of this large long-term strategic HIV trial', HIV Medicine, vol. 16, pp. 1 - 9, http://dx.doi.org/10.1111/hiv.12227

Inder KJ; Hussain R; Allen J; Brew B; Lewin TJ; Attia J; Kelly BJ, 2015, 'Factors associated with personal hopefulness in older rural and urban residents of New South Wales', Advances in Mental Health, vol. 13, pp. 43 - 57, http://dx.doi.org/10.1080/18374905.2015.1039186

Calic Z; Cappelen-Smith C; Hodgkinson SJ; McDougall A; Cuganesan R; Brew BJ, 2015, 'Treatment of progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome with intravenous immunoglobulin in a patient with multiple sclerosis treated with fingolimod after discontinuation of natalizumab', Journal of Clinical Neuroscience, vol. 22, pp. 598 - 600, http://dx.doi.org/10.1016/j.jocn.2014.08.016

Sundaram G; Brew BJ; Jones SP; Adams S; Lim CK; Guillemin GJ, 2014, 'Quinolinic acid toxicity on oligodendroglial cells: Relevance for multiple sclerosis and therapeutic strategies', Journal of Neuroinflammation, vol. 11, http://dx.doi.org/10.1186/s12974-014-0204-5

Adams S; Teo C; McDonald KL; Zinger A; Bustamante S; Lim CK; Sundaram G; Braidy N; Brew BJ; Guillemin GJ, 2014, 'Involvement of the Kynurenine Pathway in Human Glioma Pathophysiology', PLOS ONE, vol. 9, http://dx.doi.org/10.1371/journal.pone.0112945

Broadley SA; Barnett MH; Boggild M; Brew BJ; Butzkueven H; Heard R; Hodgkinson S; Kermode AG; Lechner-Scott J; Macdonell RAL; Marriott M; Mason DF; Parratt J; Reddel SW; Shaw CP; Slee M; Spies J; Taylor BV; Carroll WM; Kilpatrick TJ; King J; McCombe PA; Pollard JD; Willoughby E, 2014, 'Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 1 Historical and established therapies', Journal of Clinical Neuroscience, vol. 21, pp. 1835 - 1846, http://dx.doi.org/10.1016/j.jocn.2014.01.016

Broadley SA; Barnett MH; Boggild M; Brew BJ; Butzkueven H; Heard R; Hodgkinson S; Kermode AG; Lechner-Scott J; Macdonell RAL; Marriott M; Mason DF; Parratt J; Reddel SW; Shaw CP; Slee M; Spies J; Taylor BV; Carroll WM; Kilpatrick TJ; King J; McCombe PA; Pollard JD; Willoughby E, 2014, 'Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 2 New and emerging therapies and their efficacy', Journal of Clinical Neuroscience, vol. 21, pp. 1847 - 1856, http://dx.doi.org/10.1016/j.jocn.2014.01.018

Broadley SA; Barnett MH; Boggild M; Brew BJ; Butzkueven H; Heard R; Hodgkinson S; Kermode AG; Lechner-Scott J; Macdonell RAL; Marriott M; Mason DF; Parratt J; Reddel SW; Shaw CP; Slee M; Spies J; Taylor BV; Carroll WM; Kilpatrick TJ; King J; McCombe PA; Pollard JD; Willoughby E, 2014, 'Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 3 Treatment practicalities and recommendations', Journal of Clinical Neuroscience, vol. 21, pp. 1857 - 1865, http://dx.doi.org/10.1016/j.jocn.2014.01.017

Chan P; Brew BJ, 2014, 'HIV associated neurocognitive disorders in the modern antiviral treatment era: prevalence, characteristics, biomarkers, and effects of treatment', Current HIV/AIDS reports, vol. 11, pp. 317 - 324, http://dx.doi.org/10.1007/s11904-014-0221-0

Chan P; Brew BJ, 2014, 'HIV associated neurocognitive disorders in the modern antiviral treatment era: prevalence, characteristics, biomarkers, and effects of treatment', Current HIV/AIDS reports, vol. 11, pp. 317 - 324, http://dx.doi.org/10.1007/s11904-014-0221-0

Braidy N; Brew BJ; Inestrosa NC; Chung R; Sachdev P; Guillemin GJ, 2014, 'Changes in Cathepsin D and Beclin-1 mRNA and protein expression by the excitotoxin quinolinic acid in human astrocytes and neurons', Metabolic brain disease, vol. 29, pp. 873 - 883, http://dx.doi.org/10.1007/s11011-014-9557-9

Dwyer R; Wenhui L; Cysique L; Brew BJ; Lal L; Bain P; Wesselingh S; Wright EJ, 2014, 'Symptoms of depression and rates of neurocognitive impairment in HIV positive patients in Beijing, China', Journal of Affective Disorders, vol. 162, pp. 89 - 95, http://dx.doi.org/10.1016/j.jad.2014.03.038

Lu GM; Brew BJ; Siefried KJ; Draper B; Cysique LA, 2014, 'Is the HIV dementia scale a reliable tool for assessing HIV-relatedneurocognitive decline?', Journal of AIDS and Clinical Research, vol. 5, http://dx.doi.org/10.4172/2155-6113.1000269

Cysique LA; Brew BJ, 2014, 'The effects of HIV and aging on brain functions: Proposing a research framework and update on last 3 years' findings', Current Opinion in HIV and AIDS, vol. 9, pp. 355 - 364, http://dx.doi.org/10.1097/COH.0000000000000078

Brew BJ; Chan P, 2014, 'Update on HIV dementia and HIV-associated neurocognitive disorders', Current Neurology and Neuroscience Reports, vol. 14, http://dx.doi.org/10.1007/s11910-014-0468-2

Cysique LA; Heaton RK; Kamminga J; Lane T; Gates TM; Moore DM; Hubner E; Carr A; Brew BJ, 2014, 'HIV-associated neurocognitive disorder in Australia: a case of a high-functioning and optimally treated cohort and implications for international neuroHIV research', Journal of NeuroVirology, vol. 20, pp. 258 - 268, http://dx.doi.org/10.1007/s13365-014-0242-x

Power C; Brew BJ, 2014, 'HIV-1 infection and the nervous system-a shifting target.', Current Opinion in HIV and AIDS, vol. 9, pp. 515 - 516, http://dx.doi.org/10.1097/COH.0000000000000113

Crossley KM; Brew BJ, 2013, 'Neurological complications in controlled HIV infection', Current Infectious Disease Reports, vol. 15, pp. 564 - 568, http://dx.doi.org/10.1007/s11908-013-0375-8

Braidy N; Lim CK; Grant R; Brew BJ; Guillemin GJ, 2013, 'Serum nicotinamide adenine dinucleotide levels through disease course in multiple sclerosis', Brain Research, vol. 1537, pp. 267 - 272, http://dx.doi.org/10.1016/j.brainres.2013.08.025

Clifford DB; Nath A; Cinque P; Brew BJ; Zivadinov R; Gorelik L; Zhao Z; Duda P, 2013, 'A study of mefloquine treatment for progressive multifocal leukoencephalopathy: Results and exploration of predictors of PML outcomes', Journal of NeuroVirology, vol. 19, pp. 351 - 358, http://dx.doi.org/10.1007/s13365-013-0173-y

Grund B; Wright EJ; Brew BJ; Price RW; Roediger MP; Bain MP; Hoy JF; Shlay JC; Vjecha MJ; Robertson KR, 2013, 'Improved neurocognitive test performance in both arms of the SMART study: Impact of practice effect', Journal of NeuroVirology, vol. 19, pp. 383 - 392, http://dx.doi.org/10.1007/s13365-013-0190-x

LeWitt PA; Boroojerdi B; Surmann E; Poewe W, 2013, 'Rotigotine transdermal system for long-term treatment of patients with advanced Parkinson's disease: results of two open-label extension studies, CLEOPATRA-PD and PREFER', JOURNAL OF NEURAL TRANSMISSION, vol. 120, pp. 1069 - 1081, http://dx.doi.org/10.1007/s00702-012-0925-5

Peluso MJ; Meyerhoff DJ; Price RW; Peterson J; Lee E; Young AC; Walter R; Fuchs D; Brew BJ; Cinque P; Robertson K; Hagberg L; Zetterberg H; Gisslén M; Spudich S, 2013, 'Cerebrospinal fluid and neuroimaging biomarker abnormalities suggest early neurological injury in a subset of individuals during primary HIV infection', Journal of Infectious Diseases, vol. 207, pp. 1703 - 1712, http://dx.doi.org/10.1093/infdis/jit088

Mora-Peris B; MacKie NE; Suan D; Cooper DA; Brew BJ; Winston A, 2013, 'Raltegravir resistance in the cerebrospinal fluid', Infection, vol. 41, pp. 731 - 734, http://dx.doi.org/10.1007/s15010-013-0409-z

2013, 'The NRTIs Lamivudine, Stavudine and Zidovudine Have Reduced HIV-1 Inhibitory Activity in Astrocytes', PLoS ONE, vol. 8, http://dx.doi.org/10.1371/journal.pone.0062196

Antinori A; Arendt G; Grant I; Letendre S; Muñoz-Moreno JA; Eggers C; Brew B; Brouillette MJ; Bernal-Cano F; Carvalhal A; Christo PP; Cinque P; Cysique L; Ellis R; Everall I; Gasnault J; Husstedt I; Korten V; Machala L; Obermann M; Ouakinin S; Podzamczer D; Portegies P; Rackstraw S; Rourke S; Sherr L; Streinu-Cercel A; Winston A; Wojna V; Yazdanpannah Y; Arbess G; Baril JG; Begovac J; Bergin C; Bonfanti P; Bonora S; Brinkman K; Canestri A; Cholewinska-Szymanska G; Chowers M; Cooney J; Corti M; Doherty C; Elbirt D; Esser S; Florence E; Force G; Gill J; Goffard JC; Harrer T; Li P; Van De Kerckhove L; Knecht G; Matsushita S; Matulionyte R; McConkey S; Mouglignier A; Oka S; Penalva A; Riesenberg K; Sambatakou H; Tozzi V; Vassallo M; Wetterberg P; Drapato AW, 2013, 'Assessment, diagnosisand treatment of Human Immunodeficiency Virus (HIV)-associated neurocognitive disorders (HAND): A consensus report of the mind exchange program', Clinical Infectious Diseases, vol. 56, pp. 1004 - 1017, http://dx.doi.org/10.1093/cid/cis975

Brew BJ; McLean CA; Major EO, 2013, 'Progressive multifocal leukoencephalopathy caused by BK virus?', Medical Journal of Australia, vol. 198, pp. 179 - 180, http://dx.doi.org/10.5694/mja12.11798

Brew BJ; Gray L; Lewin S; Churchill M, 2013, 'Is specific HIV eradication from the brain possible or needed?', Expert Opinion on Biological Therapy, vol. 13, pp. 403 - 409, http://dx.doi.org/10.1517/14712598.2013.748029

Joseph J; Achim CL; Boivin MJ; Brew BJ; Clifford DB; Colosi DA; Ellis RJ; Heaton RK; Gallo-Diop A; Grant I; Kanmogne GD; Kumar M; Letendre S; Marcotte TD; Nath A; Pardo CA; Paul RH; Pulliam L; Robertson K; Royal W; Sacktor N; Sithinamsuwan P; Smith DM; Valcour V; Wigdahl B; Wood C, 2013, 'Global NeuroAIDS roundtable', Journal of NeuroVirology, vol. 19, pp. 1 - 9, http://dx.doi.org/10.1007/s13365-012-0143-9

Brown S; Simpson DM; Moyle G; Brew BJ; Schifitto G; Larbalestier N; Orkin C; Fisher M; Vanhove GF; Tobias JK, 2013, 'NGX-4010, a capsaicin 8% patch, for the treatment of painful HIV-associated distal sensory polyneuropathy: Integrated analysis of two phase III, randomized, controlled trials', AIDS Research and Therapy, vol. 10, http://dx.doi.org/10.1186/1742-6405-10-5

Jones SP; Guillemin GJ; Brew BJ, 2013, 'The kynurenine pathway in stem cell biology', International Journal of Tryptophan Research, vol. 6, pp. 57 - 66, http://dx.doi.org/10.4137/IJTR.S12626

Wu W; Nicolazzo JA; Wen L; Chung RS; Stankovic RK; Bao SS; Lim CKE; Brew BJ; Cullen KM; Guillemin GJ, 2013, 'Expression of Tryptophan 2,3-Dioxygenase and Production of Kynurenine Pathway Metabolites in Triple Transgenic Mice and Human Alzheimer's Disease Brain', PLoS One, vol. 8, pp. Article numbere59749, http://dx.doi.org/10.1371/journal.pone.0059749

Sasson SC; Oon A; Chagantri J; Brew BJ; Carr A, 2013, 'Posterior reversible encephalopathy syndrome (PRES) in an HIV-1 infected patient with disseminated varicella zoster virus: a case report', BMC Infectious Diseases, vol. 13, pp. 396 - 396, http://dx.doi.org/10.1186/1471-2334-13-396

Braidy N; Lim CK; Guillemin GJ; Grant R; Brew BJ, 2013, 'Serum nicotinamide adenine dinucleotide levels through disease course in multiple sclerosis', Brain Research, http://dx.doi.org/10.1016/j.brainres.2013.08.025

Kamminga J; Cysique LA; Lu G; Batchelor J; Brew BJ, 2013, 'Validity of Cognitive Screens for HIV-Associated Neurocognitive Disorder: A Systematic Review and an Informed Screen Selection Guide', Current HIV/AIDS Reports, vol. 10, pp. 342 - 355, http://dx.doi.org/10.1007/s11904-013-0176-6

Adams S; Braidy N; Bessede A; Brew BJ; Grant R; Teo C; Guillemin GJ, 2012, 'Correction: The kynurenine pathway in brain tumor pathogenesis (Cancer Research (2012) 72, (5649-5657))', Cancer Research, vol. 72, pp. 6524, http://dx.doi.org/10.1158/0008-5472.CAN-12-4230

Lim CK; Yap MMC; Kent SJ; Gras G; Samah B; Batten JC; De Rose R; Heng B; Brew BJ; Guillemin GJ, 2012, 'Characterization of the Kynurenine pathway and quinolinic acid production in macaque macrophages', International Journal of Tryptophan Research, vol. 6, pp. 7 - 19, http://dx.doi.org/10.4137/IJTR.S11789

Cysique L; Brew B, 2012, 'Characteristics of neurocognitive decline in virally-suppressed middle-aged HIV plus individuals', JOURNAL OF NEUROVIROLOGY, vol. 18, pp. 26 - 26, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000304487800054&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Chew C; Cysique L; Brew B; Price P, 2012, 'Relationships between genetic markers of neuroinflammation, neurodegeneration and neurocognitive impairment in controlled HIV infection', JOURNAL OF NEUROVIROLOGY, vol. 18, pp. 23 - 24, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000304487800048&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Peluso M; Price R; Peterson J; Lee E; Fuchs D; Brew B; Cinque P; Hagberg L; Zetterberg H; Gisslen M; Spudich S, 2012, 'Primary HIV-1 infection is characterized by elevation of cerebrospinal fluid biomarkers indicating early neuronal damage', JOURNAL OF NEUROVIROLOGY, vol. 18, pp. 83 - 84, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000304487800171&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Gray L; Tachedjian G; Ellett A; Roche M; Brew B; Turville S; Wesselingh S; Gorry P; Churchill M, 2012, 'Reduced Effectiveness of the NRTIs d4T and AZT in Astrocytes: Implications for Neuro-cART', JOURNAL OF NEUROVIROLOGY, vol. 18, pp. 42 - 43, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000304487800089&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Brew BJ; Thompson J, 2012, 'Epilepsy: Issues with antiepileptic drug use in HIV-infected patients', Nature Reviews Neurology, vol. 8, pp. 187 - 188, http://dx.doi.org/10.1038/nrneurol.2012.36

Mothobi NZ; Brew BJ, 2012, 'Neurocognitive dysfunction in the highly active antiretroviral therapy era', Current Opinion in Infectious Diseases, vol. 25, pp. 4 - 9, http://dx.doi.org/10.1097/QCO.0b013e32834ef586

Adams S; Braidy N; Bess A; Brew BJ; Grant RS; Teo C; Guillemin GJ, 2012, 'The kynurenine pathway in brain tumor pathogenesis', Cancer research, vol. 72, pp. 5649 - 5657, http://dx.doi.org/10.1158/0008-5472.CAN-12-0549

Lane TA; Batchelor J; Brew BJ; Cysique LA, 2012, 'Facial emotional processing in HIV infection: relation to neurocognitive and neuropsychiatric status', Neuropsychology, vol. 26, pp. 713 - 722, http://dx.doi.org/10.1037/a0029964

Cruse B; Cysique LA; Markus R; Brew BJ, 2012, 'Cerebrovascular disease in HIV-infected individuals in the era of highly active antiretroviral therapy', Journal of Neurovirology, vol. 18, pp. 264 - 276, http://dx.doi.org/10.1007/s13365-012-0092-3

Kandanearatchi ; Brew BJ, 2012, 'The kynurenine pathway and quinolinic acid: Pivotal roles in HIV associated neurocognitive disorders', FEBS Journal, vol. 279, pp. 1366 - 1374, http://dx.doi.org/10.1111/j.1742-4658.2012.08500.x

Blair N; Brew BJ; Halpern J, 2012, 'Natalizumab-associated PML identified in the presymptomatic phase using MRI surveillance', Neurology, vol. 78, pp. 507 - 508, http://dx.doi.org/10.1212/WNL.0b013e318246d6d8

Clifford D; Simpson D; Brown S; Moyle G; Brew BJ; Conway B; Tobias J; Vanhove J, 2012, 'A Randomized, Double-Blind, Controlled Study of NGX-4010, a Capsaicin 8% Dermal Patch, for the Treatment of Painful HIV-Associated Distal Sensory Polyneuropathy', JAIDS: Journal of Acquired Immune Deficiency Syndromes, vol. 59, pp. 126 - 133, http://dx.doi.org/10.1097/QAI.0b013e31823e31f7

Cysique L; Bain ; Lane ; Brew B, 2012, 'Management issues in HIV-associated neurocognitive disorders', Neurobehavioral HIV Medicine, pp. 63 - 63, http://dx.doi.org/10.2147/nbhiv.s30466

Lee M-C; Ting KK; Adams S; Brew BJ; Chung R; Guillemin GJ, 2012, 'Characterisation of the expression of NMDA receptors in human primary astrocytes', Neurology, Psychiatry and Brain Research, vol. 18, pp. 57 - 57, http://dx.doi.org/10.1016/j.npbr.2012.02.017

Maruszak H; Brew BJ; Giovannoni G; Gold J, 2011, 'Could antiretroviral drugs be effective in multiple sclerosis? A case report', European Journal of Neurology, vol. 18, http://dx.doi.org/10.1111/j.1468-1331.2011.03430.x

Wright E; Grund B; Robertson K; Brew B; Price R, 2011, 'Reply from the authors', Neurology, vol. 77, pp. 407, http://dx.doi.org/10.1212/WNL.0b013e3182246fb2

Jawaid A; Pradeep V; Shamsi A; Schulz PE, 2011, 'Cardiovascular risk factors associated with lower baseline cognitive performance in HIV-positive persons.', Neurology, vol. 77, pp. 406 - 407, http://dx.doi.org/10.1212/WNL.0b013e3182246ffb

Wright E; Grund B; Robertson K; Brew B; Price R, 2011, 'CARDIOVASCULAR RISK FACTORS ASSOCIATED WITH LOWER BASELINE COGNITIVE PERFORMANCE IN HIV-POSITIVE PERSONS Reply', NEUROLOGY, vol. 77, pp. 407 - 407, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000293123300026&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Maruszak A; Brew BJ; Giovannoni G; Gold J, 2011, 'Could antiretroviral drugs be effective in multiple sclerosis? A case report', European Journal of Neurology, vol. 18, pp. 110 - 111, http://dx.doi.org/10.1111/j.1468-1331.2011.03430.x/pdf

Maher A; Cysique LA; Brew BJ; Rae CD, 2011, 'Statistical integration of 1H NMR and MRS data from difefrent biofluids and tissues enhances recovery of biological information from individuals with HIV-1 infection', Journal of Proteome Research, vol. 10, pp. 1737 - 1745, http://dx.doi.org/10.1021/pr1010263

Chen Y; Brew BJ; Guillemin GJ, 2011, 'Characterization of the kynurenine pathway in NSC-34 cell line: implications for amyotrophic lateral sclerosis', Journal of Neurochemistry, vol. 118, pp. 816 - 825, http://dx.doi.org/10.1111/j.1471-4159.2010.07159.x/abstract;jsessionid=83A44016D40A402F78AD97483FD7AAFE.d02t04?systemMessage=Wiley+Online+Library+will+be+disrupted+14+May+from+10-12+BST+for+monthly+maintenance

McManus H; Lim P; Nolan D; Bloch M; Kiertiburanakul S; Choi J; Mulhall BP; Petoumenos K; Zhou J; Law MG; Brew BJ; Wright E, 2011, 'Does use of antiretroviral therapy regimens with high central nervous system penetration improve survival in HIV-infected adults?', HIV Medicine, vol. 12, pp. 610 - 619, http://dx.doi.org/10.1111/j.1468-1293.2011.00938.x

Cysique LA; Bain MP; Brew BJ; Murray JM, 2011, 'The burden of HIV-associated neurocognitive impairment in Australia and its estimates for the future', Sexual Health, vol. 8, pp. 541 - 550, http://dx.doi.org/10.1071/SH11003

Hillman R; Pett SL; Marriott D; Carr AD; Cooper DA; Matthews GV; Brew BJ; Milliken S; Botes LP, 2011, 'Participants' perspectives of high resolution anoscopy', Sexual Health, vol. 8, pp. 255 - 256, http://dx.doi.org/10.1071/SH10116

Botes LP; Jin F; Bourne CP; Pett SL; Marriott D; Carr AD; Cooper DA; Matthews G; Brew BJ; Hillman R, 2011, 'Participants' perspectives of self-collected anal cytological swabs', Sexual Health, vol. 8, pp. 257 - 258, http://dx.doi.org/10.1071/SH10037

Cysique LA; Waters EK; Brew BJ, 2011, 'Central nervous system antiretroviral efficacy in HIV infection: a qualitative and quantitative review and implications for future research', BMC NEUROLOGY, vol. 11, pp. 148 - 158, http://dx.doi.org/10.1186/1471-2377-11-148

Rahman A; Brew BJ; Guillemin GJ, 2011, 'Lead dysregulates serine/threonine protein phosphatases in human neurons', Neurochemical Research, vol. 36, pp. 195 - 204, http://dx.doi.org/10.1007/s11064-010-0300-6

Spudich S; Gisslen M; Hagberg L; Lee E; Liegler T; Brew BJ; Fuchs A; Tambussi G; Cinque P; Hecht FM; Price R, 2011, 'Central nervous system immune activation characterizes primary HIV-1 infection even in subjects with minimal cerebrospinal fluid viral burden', Journal of Infectious Diseases, vol. 204, pp. 753 - 760, http://dx.doi.org/10.1093/infdis/jir387

Ng K; Kumar KR; Brew BJ; Burke D, 2011, 'Axonal excitability in viral polyneuropathy and nucleoside neuropathy in HIV patients', Journal of Neurology Neurosurgery and Psychiatry, vol. 82, pp. 978 - 980, http://dx.doi.org/10.1136/jnnp.2009.203091

Tippett M; Cheng W; Westhorpe R; Cameron A; Brew BJ; Lewin S; Jaworowski A; Crowe S, 2011, 'Differential expression of CD163 on monocyte subsets in healthy and HIV-1 infected individuals', PLoS One, vol. 6, pp. 1 - 11, http://dx.doi.org/10.1371/journal.pone.0019968

Croitoru-Lamoury J; Lamoury F; Caristo M; Suzuki K; Walker DW; Takikawa O; Taylor R; Brew BJ, 2011, 'Interferon-c Regulates the Proliferation and differentiation of mesenchymal stem cells via activation of indoleamine 2,3 dioxygenase (IDO)', PLoS One, vol. 6, pp. 1 - 13, http://dx.doi.org/10.1371/journal.pone.0014698

Wu W; Cullen K; Stankovic R; Bao S; Bell J; Brew B; Guillemin G, 2011, 'P4‐035: Quinolinic acid in HIV‐1‐associated dementia with pathogenetic processes distinct from Alzheimer disease', Alzheimer's & Dementia, vol. 7, pp. S710 - S710, http://dx.doi.org/10.1016/j.jalz.2011.05.2055

Tisch S; Brew BJ, 2010, 'HIV, HAART, and parkinson's disease: Co-incidence or pathogenetic link?', Movement Disorders, vol. 25, pp. 2257 - 2258, http://dx.doi.org/10.1002/mds.23277

Guillemin GJ; Rahman A; Ting K; Cullen KM; Braidy N; Chung RS; Wu W; Brew BJ, 2010, 'INVOLVEMENT OF THE KYNURENINE PATHWAY IN ALZHEIMER'S DISEASE', JOURNAL OF NEUROCHEMISTRY, vol. 115, pp. 39 - 39, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000281812600096&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Zhou L; Diefenbach E; Crossett B; Tran SL; Ng T; Rizos H; Rua R; Wang B; Kapur A; Gandhi K; Brew BJ; Saksena NK, 2010, 'First evidence of overlaps between HIV-associated dementia (HAD) and non-viral neurodegenerative diseases: Proteomic analysis of the frontal cortex from HIV+ patients with and without dementia', Molecular Neurodegeneration, vol. 5, http://dx.doi.org/10.1186/1750-1326-5-27

Brew BJ; Cysique LA, 2010, 'Editorial: Alzheimer disease and HIV: A tangled story', Neurology, vol. 75, pp. 105 - 106, http://dx.doi.org/10.1212/WNL.0b013e3181e7b6a4

Hagberg L; Cinque P; Gisslen M; Brew BJ; Spudich S; Bestetti A; Price RW; Fuchs D, 2010, 'Cerebrospinal fluid neopterin: An informative biomarker of central nervous system immune activation in HIV-1 infection', AIDS Research and Therapy, vol. 7, http://dx.doi.org/10.1186/1742-6405-7-15

McArthur JC; Brew BJ, 2010, 'HIV-associated neurocognitive disorders: Is there a hidden epidemic?', AIDS, vol. 24, pp. 1367 - 1370, http://dx.doi.org/10.1097/QAD.0b013e3283391d56

Brew BJ, 2010, 'HIV-Associated Cerebral Opportunistic Infections', International Neurology: A Clinical Approach, pp. 356 - 359, http://dx.doi.org/10.1002/9781444317008.ch97

Brew BJ, 2010, 'HIV-Associated Lymphoma: Neurologic Complications', International Neurology: A Clinical Approach, pp. 360 - 361, http://dx.doi.org/10.1002/9781444317008.ch98

Brew BJ, 2010, 'HIV and the Acquired Immunodeficiency Syndrome: An Overview of Neurological Complications', International Neurology: A Clinical Approach, pp. 340 - 341, http://dx.doi.org/10.1002/9781444317008.ch92

Cherry CL; Affandi JS; Brew BJ; Creighton J; Djauzi S; Hooker DJ; Imran D; Kamarulzaman A; Kamerman P; McArthur JC; Moore RD; Price P; Smyth K; Tan IL; Vanar S; Wadley A; Wesselingh SL; Yunihastuti E, 2010, 'Hepatitis C seropositivity is not a risk factor for sensory neuropathy among patients with HIV', Neurology, vol. 74, pp. 1538 - 1542, http://dx.doi.org/10.1212/WNL.0b013e3181dd436d

Brew BJ, 2010, 'Neurodegeneration in the HAART era', RETROVIROLOGY, vol. 7, pp. 3 - 3, http://dx.doi.org/10.1186/1742-4690-7-S1-I7

Brew BJ, 2010, 'Benefit or toxicity from neurologically targeted antiretroviral therapy?', Clinical Infectious Diseases, vol. 50, pp. 930 - 932, http://dx.doi.org/10.1086/650744

Lim CK; Brew BJ; Sundaram G; Guillemin GJ, 2010, 'Understanding the roles of the kynurenine pathway in multiple sclerosis progression', International Journal of Tryptophan Research, vol. 3, pp. 157 - 167, http://dx.doi.org/10.4137/ijtr.s4294

Davies NWS; Guillemin G; Brew BJ, 2010, 'Tryptophan, neurodegeneration and HIV-associated neurocognitive disorder', International Journal of Tryptophan Research, vol. 3, pp. 121 - 140, http://dx.doi.org/10.4137/ijtr.s4321

Lifson A; Belloso W; Davey R; Duprez D; Gatell J; Hoy J; Krum E; Nelson R; Pedersen C; Perez G; Price R; Prineas R; Rhame F; Sampson J; Worley J, 2010, 'Development of diagnostic criteria for serious non-AIDS events in HIV clinical trials', HIV Clinical Trials, vol. 11, pp. 205 - 219, http://dx.doi.org/10.1310/hct1104-205

Dunbar M; Murray JM; Cysique LA; Brew BJ; Jeyakumar V, 2010, 'Simultaneous classification and feature selection via convex quadratic programming with application to HIV-associated neurocognitive disorder assessment', European Journal of Operational Research, vol. 206, pp. 470 - 478, http://dx.doi.org/10.1016/j.ejor.2010.03.017

Lee M; Ting KK; Adams S; Brew BJ; Chung R; Guillemin GJ, 2010, 'Characterisation of the expression of NMDA receptors in human astrocytes', PLoS One, vol. 5, pp. e14123, http://dx.doi.org/10.1371/journal.pone.0014123

Brew BJ; Davies NWS; Cinque P; Clifford D; Nath A, 2010, 'Progressive multifocal leukoencephalopathy and other forms of JC virus disease', Nature Reviews Neuroscience, vol. 6, pp. 667 - 679, http://dx.doi.org/10.1038/nrneurol.2010.164

Cherry C; Brew B; Downs C; Gregorio-King C; Cooke I; Rennie G; Goodchild C, 2010, '270 FLUPIRTINE AS AN ADJUNCT TO OPIOID ANALGESIA IN HIV NEUROPATHY PAIN', European Journal of Pain Supplements, vol. 4, pp. 78 - 78, http://dx.doi.org/10.1016/s1754-3207(10)70275-3

Brew B, 2010, 'A guide to interpretation of neuroimmunological biomarkers in the combined antiretroviral therapy-era of HIV central nervous system disease', Neurobehavioral HIV Medicine, pp. 59 - 59, http://dx.doi.org/10.2147/nbhiv.s7167

Guillemin GJ; Rahman A; Ting KK; Cullen K; Braidy N; Chung R; Wu W; Brew BJ, 2010, 'P4‐002: Involvement of the Kynurenine Pathway in Alzheimer's Disease', Alzheimer's & Dementia, vol. 6, pp. e21 - e21, http://dx.doi.org/10.1016/j.jalz.2010.08.063

Ng K; Kumar K; Brew B; Burke D, 2010, '4. The electrophysiological features of HIV peripheral neuropathy', Clinical Neurophysiology, vol. 121, pp. e2 - e2, http://dx.doi.org/10.1016/j.clinph.2009.10.024

Gisslén M; Krut J; Andreasson U; Blennow K; Cinque P; Brew BJ; Spudich S; Hagberg L; Rosengren L; Price RW; Zetterberg H, 2009, 'Amyloid and tau cerebrospinal fluid biomarkers in HIV infection', BMC Neurology, vol. 9, http://dx.doi.org/10.1186/1471-2377-9-63

Joseph J; Clifford D; Douglas SD; Fox H; Gendelman HE; Gonzalez-Scarano F; Grant I; Major E; McArthur J, 2009, 'Planning Future Strategies for Domestic and International NeuroAIDS Research, July 24-25, 2008', JOURNAL OF NEUROIMMUNE PHARMACOLOGY, vol. 4, pp. 283 - 297, http://dx.doi.org/10.1007/s11481-009-9159-1

Gray L; Roche M; Churchill MJ; Sterjovski J; Ellett A; Poumbourios P; Sherieff S; Wang B; Saksena N; Purcell DFJ; Wesselingh S; Cunningham AL; Brew BJ; Gabuzda D; Gorry PR, 2009, 'Tissue-specific sequence alterations in the human immunodeficiency virus type 1 envelope favoring CCR5 usage contribute to persistence of dual-tropic virus in the brain (Journal of Virology (2009) 83, 11, (5430-5441))', Journal of Virology, vol. 83, pp. 7794, http://dx.doi.org/10.1128/JVI.01082-09

Churchill MJ; Wesselingh SL; Cowley D; Pardo CA; McArthur JC; Brew BJ; Gorry PR, 2009, 'Extensive astrocyte infection is prominent in human immunodeficiency virus - associated dementia', Annals of Neurology, vol. 66, pp. 253 - 258, http://dx.doi.org/10.1002/ana.21697

Gray L; Roche M; Churchill MJ; Sterjovski J; Ellett A; Poumbourios P; Sheffief S; Wang B; Saksena N; Purcell DFJ; Wesselingh S; Cunningham AL; Brew BJ; Gabuzda D; Gorry PR, 2009, 'Tissue-specific sequence alterations in the human immunodeficiency virus type 1 envelope favoring CCR5 usage contribute to persistence of dual-tropic virus in the brain', Journal of Virology, vol. 83, pp. 5430 - 5441, http://dx.doi.org/10.1128/JVI.02648-08

Tan IL; Brew BJ, 2009, 'Possible JCV granular cell neuronopathy in a patient with HIV infection', Neurology, vol. 73, pp. 1598 - 1599, http://dx.doi.org/10.1212/WNL.0b013e3181c0d6cb

Sher L; Cramer D; Grinyer J; Hall BM; Brayman K; Mirmira R, 2009, 'Editorial introductions', Current Opinion in Organ Transplantation, vol. 14

Cysique LA; Brew BJ, 2009, 'Neuropsychological functioning and antiretroviral treatment in HIV/AIDS: A review', Neuropsychology Review, vol. 19, pp. 169 - 185, http://dx.doi.org/10.1007/s11065-009-9092-3

Brew BJ; Crowe S; Landay A; Cysique LA; Guillemin GJ, 2009, 'Neurodegeneration and ageing in the HAART era', JOURNAL OF NEUROIMMUNE PHARMACOLOGY, vol. 4, pp. 163 - 174, http://dx.doi.org/10.1007/s11481-008-9143-1

Ting KK; Brew BJ; Guillemin GJ, 2009, 'Effect of quinolinic acid on human astrocytes morphology and functions: implications in Alzheimer's disease', Journal of Neuroinflammation, vol. 6, pp. 1 - 13, http://dx.doi.org/10.1186/1742-2094-6-36

Braidy N; Grant RS; Brew BJ; Adams S; Jayasena T; Guillemin GJ, 2009, 'Effects of Kynurenine Pathway Metabolites on Intracellular NAD+ Synthesis and Cell Death in Human Primary Astrocytes and Neurons', International Journal of Tryptophan Research : IJTR, vol. 2, pp. 61 - 69

Brew BJ, 2009, 'HIV, the brain, children, HAART and `neuro-HAART`: A complex mix', AIDS, vol. 23, pp. 1909 - 1910, http://dx.doi.org/10.1097/QAD.0b013e32832ec4c6

Rahman A; Ting K; Cullen KM; Braidy N; Brew BJ; Guillemin GJ, 2009, 'The excitotoxin quinolinic acid induces tau phosphorylation in human neurons', PLoS One, vol. 4, pp. e6344 -1 - 15, http://dx.doi.org/10.1371/journal.pone.0006344

Braidy N; Grant RS; Adams S; Brew BJ; Guillemin GJ, 2009, 'Mechanism for quinolinic acid cytotoxicity in human astrocytes & neurons', Neurotoxicity Research, vol. 16, pp. 77 - 86, http://dx.doi.org/10.1007/s12640-009-9051-z

Tisch S; Brew BJ, 2009, 'Parkinsonism in HIV-infected patients on highly active antiretroviral therapy', Neurology, vol. 73, pp. 401 - 403, http://dx.doi.org/10.1212/WNL.0b013e3181b04b0d

Maruff P; Thomas E; Cysique LA; Brew BJ; Collie A; Snyder P; Pietrzak R, 2009, 'Validity of the CogState Brief Battery: Relationship to Standardized Tests and Sensitivity to Cognitive Impairment in Mild Traumatic Brain Injury, Schizophrenia, and AIDS Dementia Complex', Archives of Clinical Neuropsychology, vol. 24, pp. 165 - 178, http://dx.doi.org/10.1093/arclin/acp010

Brew B; Tisch S, 2009, '20. Parkinsonism in HIV-infected patients on highly active antiretroviral therapy', Journal of Clinical Neuroscience, vol. 16, pp. 1531 - 1531, http://dx.doi.org/10.1016/j.jocn.2009.07.045

Brew BJ; Gisslen M; Pemberton L; Cinque P; Hagberg L; Price RW; Blennow K; Spudich S, 2009, '110. CSF t-tau, p-tau and Amyloid Beta 1-42 in HIV Infection', Journal of Clinical Neuroscience, vol. 16, pp. 464 - 464, http://dx.doi.org/10.1016/j.jocn.2008.07.009

Guillemin GJ; Rahman A; Cullen KM; Ting KK; Braidy N; Brew BJ, 2009, 'P3‐195: Involvement of the kynurenine pathway in Alzheimer's disease', Alzheimer's & Dementia, vol. 5, pp. P400 - P400, http://dx.doi.org/10.1016/j.jalz.2009.04.1069

Maneglier B; Guillemin G; Clayette P; Brew B; Rogez-Kreuz C; Advenier C; Spreux-Varoquaux O, 2008, 'Involvement of tryptophan catabolism during HIV-1 infection in primary culture of human monocytes-derived macrophages', FUNDAMENTAL & CLINICAL PHARMACOLOGY, vol. 22, pp. 99 - 99, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000256760500481&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Batmanian JJ; Lam M; Matthews C; Finckh A; Duffy M; Wright R; Brew BJ; Markus R, 2008, 'Reply', Medical Journal of Australia, vol. 188, pp. 489 - 490, http://dx.doi.org/10.5694/j.1326-5377.2008.tb01732.x

Ting KK; Brew BJ; Guillemin GJ, 2008, 'The involvement of astrocytes and kynurenine pathway in Alzheimer`s disease', Neurotoxicity Research, vol. 12, pp. 247 - 262

Wright E; Brew BJ; Arayawichanont A; Robertson K; Samintharapanya K; Kongsaengdao S; Lim M; Vonthanak S; Lal L; Sarim C; Huffam SE; Li P; Imran D; Lewis J; Lun W; Kamarulzaman A; Tau G; Ali ST; Kishore K; Bain MA; Dwyer R; McCormack G; Hellard M; Cherry C; McArthur J; Wesselingh S, 2008, 'Neurologic disorders are prevalent in HIV-positive outpatients in the Asia-Pacific region', Neurology, vol. 71, pp. 50 - 56, http://dx.doi.org/10.1212/01.wnl.0000316390.17248.65

Wright E; Brew BJ; Wesselingh S, 2008, 'Pathogenesis and diagnosis of viral infections of the nervous system', Neurologic Clinics, vol. 26, pp. 617 - 617, http://dx.doi.org/10.1016/j.ncl.2008.03.006

Owe-Young R; Webster N; Mukhtar M; Pomerantz R; Smythe GA; Walker DW; Armati P; Crowe SM; Brew BJ, 2008, 'Kynurenine pathway metabolism in human blood-brain-barrier cells: implications for immune tolerance & neurotoxicity', Journal of Neurochemistry, vol. 105, pp. 1346 - 1357, http://dx.doi.org/10.1111/j.1471-4159.2008.05241.x

Maneglier B; Guillemin GJ; Clayette P; Rogez-Kreuz C; Brew BJ; Dormont D; Advenier C; Therond P; Spreux-Varoquaux O, 2008, 'Serotonin decreases HIV-1 replication in primary cultures of human macrophages through 5-HT1A receptors', British Journal of Pharmacology, vol. 154, pp. 174 - 182, http://dx.doi.org/10.1038/bjp.2008.80

Wright E; Nunn M; Joseph J; Robertson K; Lal L; Brew BJ, 2008, 'NeuroAIDS in the Asia Pacific Region', Journal of Neurovirology, vol. 14, pp. 465 - 473, http://dx.doi.org/10.1080/13550280802235932

Pemberton LA; Stone E; Price P; van Bockxmeer FM; Brew BJ, 2008, 'The relationship between ApoE, TNFA, IL1a, IL1b and IL12b genes and HIV-1-associated dementia', HIV Medicine, vol. 9, pp. 677 - 680, http://dx.doi.org/10.1111/j.1468-1293.2008.00614.x

Cherry C; Duncan A; Mackie K; Wesselingh S; Brew BJ, 2008, 'A Report on the Effect of Commencing Enfuvirtide on Peripheral Neuropathy', AIDS Research and Human Retroviruses, vol. 24, pp. 1027 - 1030, http://dx.doi.org/10.1089/aid.2007.0300

Wright E; Brew BJ; Lal L; Ali ST; Arayawichanont A; Imran D; Kamarulzaman A; Kongsaengdao S; Kruy L; Merati T; Samintharapanya K; Sarim C; Tau G; Thangsing C; Vin-Samnang C; Wesselingh S, 2008, 'Response to Birbeck et al', Epilepsia, vol. 49, pp. 541 - 543, http://dx.doi.org/10.1111/j.1528-1167.2007.01529_5.x

Brew BJ; Letendre S, 2008, 'Biomarkers of HIV related central nervous system disease', International Review of Psychiatry, vol. 20, pp. 73 - 88, http://dx.doi.org/10.1080/09540260701878082

Batmanian JJ; Lam M; Matthews C; Finckh AS; Duffy MT; Wright RO; Brew BJ; Markus R, 2008, 'Tissue plasminogen activator for acute ischaemic stroke - Reply', Medical Journal of Australia, vol. 188, pp. 489 - 490, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000256113000019&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Cinque P; Brew BJ; Gisslen M; Hagberg L; Price RW, 2007, 'Cerebrospinal fluid markers in central nervous system HIV infection and AIDS dementia complex', Handbook of Clinical Neurology, vol. 85, pp. 261 - 300, http://dx.doi.org/10.1016/S0072-9752(07)85017-2

Brew BJ, 2007, 'AIDS dementia complex', Handbook of Clinical Neurology, vol. 85, pp. 79 - 91, http://dx.doi.org/10.1016/S0072-9752(07)85006-8

Brew BJ, 2007, 'Neurological sequelae of primary HIV infection', Handbook of Clinical Neurology, vol. 85, pp. 69 - 77, http://dx.doi.org/10.1016/S0072-9752(07)85005-6

Brew BJ; Gonzalez-Scarano F, 2007, 'Frequency of and risk factors for HIV dementia in an HIV clinic in sub-saharan Africa - Reply from the editorialists', NEUROLOGY, vol. 69, pp. 412 - 413, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000248243300024&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Brew BJ; Gonzalez-Scarano F, 2007, 'Frequency of and risk factors for HIV dementia in an HIV clinic in sub-Saharan Africa [7]', Neurology, vol. 69, pp. 412 - 413, http://dx.doi.org/10.1212/01.wnl.0000278073.28318.66

Guillemin GJ; Cullen K; Smythe GA; Kapoor V; Lim E; Garner B; Takikawa O; Brew BJ, 2007, 'Characterization of the kynurenine pathway in human neurons', Journal of the History of the Neurosciences, vol. 27, pp. 12884 - 12892

Guillemin GJ; Brew BJ; Noonan C; Knight TG; Cullen K, 2007, 'Mass spectrometric detection of quinolinic acid in microdissected Alzheimer disease plaques', International Congress Series, vol. 1304, pp. 404 - 408, http://dx.doi.org/10.1016/j.ics.2007.07.012

Guillemin GJ; Cullen K; Lim C; Smythe GA; Garner B; Kapoor V; Takikawa O; Brew BJ, 2007, 'Characterization of the kynurenine pathway in human neurons', Journal of Neuroscience, vol. 27, pp. 12884 - 12892, http://dx.doi.org/10.1523/JNEUROSCI.4101-07.2007

Batmanian JJ; Lam MK; Matthews C; Finckh AS; Duffy MT; Wright RO; Brew BJ; Markus R, 2007, 'A protocol-driven model for the rapid initiation of stroke thrombolysis in the emergency department', Medical Journal of Australia, vol. 187, pp. 567 - 570

Lim CK; Smythe GA; Stocker R; Brew BJ; Guillemin GJ, 2007, 'Characterization of the kynurenine pathway in primary human oligodendrocytes', International Congress Series, vol. 1304, pp. 213 - 217, http://dx.doi.org/10.1016/j.ics.2007.07.011

Ting KK; Brew BJ; Guillemin GJ, 2007, 'Effect of Quinolinic acid on gene expression in human Astrocytes: Implications on Alzheimer’s disease', International Congress Series, vol. 1304, pp. 384 - 388, http://dx.doi.org/10.1016/j.ics.2007.07.010

Thein H; Maruff P; Krahn M; Kaldor JM; Koorey D; Brew BJ; Dore GJ, 2007, 'Improved cognitive function as a consequence of hepatitis C virus treatment', HIV Medicine, vol. 8, pp. 520 - 528, http://dx.doi.org/10.1111/j.1468-1293.2007.00505.x

Guillemin GJ; Brew BJ, 2007, 'Chronic HIV infection leads to an Alzheimer’s disease like illness - Involvement of the kynurenine pathway', International Congress Series, vol. 1304, pp. 324 - 334, http://dx.doi.org/10.1016/j.ics.2007.07.031

Antinori A; Arendt G; Becker J; Brew BJ; Byrd D; Cherner M; Clifford D; Cinque P; Epstein L; Goodkin K; Gisslen M; Grant I; Heaton R; Joseph JE; Marder K; Marra C; McArthur J; Nunn M; Price R; Pulliam L; Robertson K; Sacktor N; Valcour V; Wojna V, 2007, 'Updated research nosology for HIV-associated neurocognitive disorders', Neurology, vol. 69, pp. 1789 - 1799, http://dx.doi.org/10.1212/01.WNL.0000287431.88658.8b

Mellgren A; Price R; Hagberg L; Rosengren L; Brew BJ; Gisslen M, 2007, 'Antiretroviral treatment reduces increased CSF neurofilament protein (NFL) in HIV-1 infection', Neurology, vol. 69 (15), pp. 1536 - 1541, http://dx.doi.org/10.1212/01.wnl.0000277635.05973.55

Brew BJ, 2007, 'HAD and the need for new trial design methodology', AIDS, vol. 21, pp. 1965 - 1966, http://dx.doi.org/10.1097/QAD.0b013e328133850e

Brew BJ, 2007, 'Lost in translation: Again, another failed neuroprotection trial', Neurology, vol. 69, pp. 1308 - 1309, http://dx.doi.org/10.1212/01.wnl.0000277530.05450.ff

Abdulle S; Mellgren A; Brew BJ; Cinque P; Hagberg L; Price R; Rosengren L; Gisslen M, 2007, 'CSF neurofilament protein (NFL) - a marker of active HIV-related neurodegeneration', Journal of Neurology, vol. 254, pp. 1026 - 1032, http://dx.doi.org/10.1007/s00415-006-0481-8

Gisslen M; Hagberg L; Brew BJ; Cinque P; Price R; Rosengren L, 2007, 'Elevated cerebrospinal fluid neurofilament light protein concentrations predict the development of AIDS dementia complex', Journal of Infectious Diseases, vol. 195, pp. 1774 - 1778, http://dx.doi.org/10.1086/518043

Thein H; Maruff P; Krahn M; Kaldor JM; Koorey D; Brew BJ; Dore GJ, 2007, 'Cognitive function, mood and health-related quality of life in hepatitis C virus (HCV)-monoinfected and HIV/HCV-coinfected individuals commencing HCV treatment', HIV Medicine, vol. 8, pp. 192 - 202, http://dx.doi.org/10.1111/j.1468-1293.2007.00452.x

Drake A; Loy CT; Brew BJ; Chen TP; Petoumenos K; Li P; Wright E, 2007, 'Human immunodeficiency virus-associated progressive multifocal leucoencephalopathy: epidemiology and predictive factors for prolonged survival', European Journal of Neurology, vol. 14, pp. 418 - 423, http://dx.doi.org/10.1111/j.1468-1331.2007.01686.x

Brew BJ; Gonzalez-Scarano F, 2007, 'HIV-associated dementia - An inconvenient truth', Neurology, vol. 68, pp. 324 - 325, http://dx.doi.org/10.1212/01.wnl.0000252803.24176.76

Gisslen M; Hagberg L; Rosengren L; Brew BJ; Cinque P; Spudich S; Price R, 2007, 'Defining and evaluating HIV-Related neurodegenerative disease and its treatment targets: A combinatorial approach to use of cerebrospinal fluid molecular biomarkers', JOURNAL OF NEUROIMMUNE PHARMACOLOGY, vol. 2, pp. 112 - 119, http://dx.doi.org/10.1007/s11481-006-9035-1

Gorry P; Mcphee D; Verity E; Dyer W; Wesselingh S; Learmont J; Sullivan JS; Roche M; Zaunders J; Gabuzda D; Crowe S; Mills J; Lewin S; Brew BJ; Cunningham AL; Churchill M, 2007, 'Pathogenicity and immunogenicity of attenuated, nef-deleted HIV-1 strains in vivo', Retrovirology, vol. 4 (66), http://dx.doi.org/10.1186/1742-4690-4-66

Croitoru-Lamoury J; Lamoury F; Zaunders J; Veas LA; Brew BJ, 2007, 'Human mesenchymal stem cells constitutively express chemokines and chemokine receptors that can be upregulated by cytokines, IFN-beta, and Copaxone', Journal of Interferon and Cytokine Research, vol. 27, pp. 53 - 64, http://dx.doi.org/10.1089/jir.2006.0037

Ting KK; Brew BJ; Guillemin GJ, 2007, 'The involvement of astrocytes and kynurenine pathway in Alzheimer`s disease', Neurotoxicity Research, vol. 12, pp. 247 - 262, http://dx.doi.org/10.1007/BF03033908

Brew BJ; Halman M; Catalan J; Sacktor N; Price R; Brown S; Atkinson H; Clifford D; Simpson D; Torres G; Hall C; Power C; Marder K; Mc Arthur J; Symonds W; Romero C, 2007, 'Factors in AIDS dementia complex trial design: Results and lessons from the abacavir trial', PLoS Clinical Trials, vol. 2, http://dx.doi.org/10.1371/journal.pctr.0020013

Brew B, 2006, 'Relativity and relativism', NEW SCIENTIST, vol. 188, pp. 27 - 27, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000234329300034&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Churchill MJ; Figueiredo A; Cowley D; Gray L; Purcell DFJ; Sullivan JS; McPhee DA; Wesselingh SL; Brew BJ; Gorry PR, 2006, 'Transcriptional activity of blood-and cerebrospinal fluid-derived nef/long-terminal repeat sequences isolated from a slow progressor infected with nef-deleted human immunodeficiency virus type 1 (HIV-1) who developed HIV-associated dementia', Journal of NeuroVirology, vol. 12, pp. 219 - 228, http://dx.doi.org/10.1080/13550280600827369

Cysique LA; Maruff P; Brew BJ, 2006, 'Valproic acid is associated with cognitive decline in HIV-infected individuals: a clinical observational study', BMC NEUROLOGY, vol. 6, pp. 42 - 42, http://dx.doi.org/10.1186/1471-2377-6-42

Cysique LA; Maruff P; Brew BJ, 2006, 'Variable benefit in neuropsychological function in HIV-infected HAART-treated patients', Neurology, vol. 66, pp. 1447 - 1450, http://dx.doi.org/10.1212/01.wnl.0000210477.63851.d3

Cysique LA; Maruff P; Darby D; Brew BJ, 2006, 'The assessment of cognitive function in advanced HIV-1 infection and AIDS dementia complex using a new computerised cognitive test battery', Archives of Clinical Neuropsychology, vol. 21, pp. 185 - 194, http://dx.doi.org/10.1016/j.acn.2005.07.011

Cysique LA; Maruff P; Brew BJ, 2006, 'The neuropsychological profile of symptomatic AIDS and ADC patients in the pre-HAART era: A meta-analysis', Journal of the International Neuropsychological Society, vol. 12, pp. 368 - 382, http://dx.doi.org/10.1017/S1355617706060401

Guillemin GJ; Meininger V; Brew BJ, 2006, 'Implications for the kynurenine pathway and quinolinic acid in amyotrophic lateral sclerosis (Review)', Neurodegenerative Diseases, vol. 2, pp. 166 - 176, http://dx.doi.org/10.1159/000089622

Croitoru-Lamoury J; Williams K; Lamoury F; Veas LA; Ajami B; Taylor R; Brew BJ, 2006, 'Neural transplantation of human MSC and NT2 cells in the twitcher mouse model', Cytotherapy, vol. 8, pp. 445 - 458, http://dx.doi.org/10.1080/14653240600879152

Lamoury F; Croitoru-Lamoury J; Brew BJ, 2006, 'Undifferentiated mouse mesenchymal stem cells spontaneously express neural and stem cell markers Oct-4 and Rex-1', Cytotherapy, vol. 8, pp. 228 - 242, http://dx.doi.org/10.1080/14653240600735875

Shah M; Smit T; Morgello S; Tourtellotte W; Gelman B; Brew BJ; Saksena N, 2006, 'Env gp120 sequence analysis of HIV type 1 strains from diverse areas of the brain shows preponderance of CCR5 usage', AIDS Research and Human Retroviruses, vol. 22, pp. 177 - 181, http://dx.doi.org/10.1089/aid.2006.22.177

Brew B, 2005, 'Relativity and relativism [9]', New Scientist, vol. 188, pp. 27

Guillemin GJ; Brew BJ; Noonan CE; Knight TG; Smythe G; Callen KM, 2005, 'Mass spectroscopic detection of quinolinic acid in microdissected Alzheimer's disease plaques', INFLAMMATION RESEARCH, vol. 54, pp. S200 - S200, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000205501600374&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Guillemin GJ; Cullen KM; Smythe GA; Brew BJ, 2005, 'Involvement of the kynurenine pathway in neuroinflammation', INFLAMMATION RESEARCH, vol. 54, pp. S199 - S199, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000205501600371&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Guillemin GJ; Wang L; Brew BJ, 2005, 'Quinolinic acid selectively induces apoptosis of human astocytes: Potential role in AIDS dementia complex', Journal of Neuroinflammation, vol. 2, http://dx.doi.org/10.1186/1742-2094-2-16

Batmanian J; Brew BJ, 2005, 'Clinical significance of central nervous system as sanctuary site for HIV', Journal of HIV therapy, vol. 10, pp. 16 - 21

Guillemin GJ; Wang L; Brew BJ, 2005, 'Quinolinic acid induces apoptosis of human astrocyte', Journal of Neuroinflammation

Guillemin GJ; Brew BJ; Noonan C; Takikawa O; Cullen K, 2005, 'Indoleamine 2,3 dioxygenase and quinolinic acid in plaque and neurons in post-mortem brain tissue from Alzheimer`s disease and control cases', Neuropathology and Applied Neurobiology, vol. 31, pp. 395 - 404

Guillemin GJ; Smythe GA; Takikawa O; Brew BJ, 2005, 'Expression of indoleamine 2,3 dioxygenase and production of quinolinic acid by human microglia, astrocytes and neurons', Glia, vol. 49, pp. 15 - 23

Cysique LA; Brew BJ; Halman M; Catalan J; Sacktor N; Price R; Brown S; Atkinson JH; Clifford D; Simpson D; Torres G; Hall C; Power C; Marder K; McArthur J; Symonds W; Romero C, 2005, 'Undetectable cerebrospinal fluid HIV RNA and beta-2 microglobulin do not indicate inactive AIDS dementia complex in highly active antiretroviral therapy-treated patients', JAIDS: Journal of Acquired Immune Deficiency Syndromes, vol. 39, pp. 426 - 429, http://dx.doi.org/10.1097/01.qai.0000165799.59322.f5

Guillemin GJ; Kerr SJ; Brew BJ, 2005, 'Involvement of quinolinic acid in AIDS dementia complex', Neurotoxicity Research, vol. 7, pp. 103 - 123, http://dx.doi.org/10.1007/BF03033781

Brew BJ; Pemberton LA; Blennow K; Wallin A; Hagberg L, 2005, 'CSF amyloid beta 42 and tau levels correlate with AIDS dementia complex', Neurology, vol. 65, pp. 1490 - 1492, http://dx.doi.org/10.1212/01.wnl.0000183293.95787.b7

McArthur J; Brew BJ; Nath A, 2005, 'Neurological complications of HIV infection', Lancet Neurology, vol. 4, pp. 543 - 555, http://dx.doi.org/10.1016/S1474-4422(05)70165-4

Guillemin GJ; Smythe GA; Takikawa O; Brew BJ, 2005, 'Expression of indoleamine 2,3-dioxygenase and production of quinolinicacid by human microglia, astrocytes, and neurons', Glia, vol. 49, pp. 15 - 23, http://dx.doi.org/10.1002/glia.20090

Winston A; Marriott D; Brew BJ, 2005, 'Early syphilis presenting as a painful polyradiculopathy in an HIV positive individual', Sexually Transmitted Infections, vol. 81, pp. 133 - 134, http://dx.doi.org/10.1136/sti.2004.011668

Berger J; Brew BJ, 2005, 'An international screening tool for HIV dementia', AIDS, vol. 19, pp. 2165 - 2166, http://dx.doi.org/10.1097/01.aids.0000194798.66670.6e

Guillemin GJ; Brew BJ; Noonan C; Takikawa O; Cullen K, 2005, 'Indoleamine 2,3 dioxygenase and quinolinic acid immunoreactivity in Alzheimer`s disease hippocampus', Neuropathology and Applied Neurobiology, vol. 31, pp. 395 - 404, http://dx.doi.org/10.1111/j.1365-2990.2005.00655.x

Brew BJ, 2005, 'HIV and the nervous system - palliative carte aspects', Journal of the Neurological Sciences, vol. 238, pp. S38 - S38, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000235088000158&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Brew BJ, 2005, 'HIV related neuromuscular disease', Journal of the Neurological Sciences, vol. 238, pp. S3 - S3, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000235088000012&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Brew BJ, 2005, 'HIV associated neurology in the developing world', Journal of the Neurological Sciences, vol. 238, pp. S22 - S22, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000235088000089&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Crowe S; Ho D; Marriott D; Brew BJ; Gorry P; Sullivan JS; Learmont JC; Mills J, 2005, 'In vivo replication kinetics of a nef-deleted strain of HIV-1', AIDS, vol. 19, pp. 842 - 843, http://dx.doi.org/10.1097/01.aids.0000168984.05209.f1

Lamour Y; Veas LA; Lamoury F; Brew BJ, 2005, 'Human mesenchymal stem cells constitutively express chemokines and chemokine receptors which can be upregulated by cytokines, ifn-beta and copaxone', Journal of the Neurological Sciences, vol. 238, pp. S233 - S233, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000235088002145&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Churchill M; Sterjovski J; Gray L; Cowley D; Chatfield C; Learmont J; Sullivan JS; Crowe SM; Mills J; Brew BJ; Wesselingh SL; McPhee DA; Gorry PR, 2004, 'Longitudinal analysis of nef/long terminal repeat-deleted HIV-1 in blood and cerebrospinal fluid of a long-term survivor who developed HIV-associated dementia', Journal of Infectious Diseases, vol. 190, pp. 2181 - 2186, http://dx.doi.org/10.1086/425585

Brew BJ, 2004, 'HAART in AIDS dementia complex and palliative care', Progress in Palliative Care, vol. 12, pp. 171 - 177, http://dx.doi.org/10.1179/096992604225006370

Brew BJ, 2004, 'Clinical aspects of AIDS dementia complex in the HAART era', JOURNAL OF NEUROVIROLOGY, vol. 10, pp. 3 - 3, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000202992000003&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Guillemin GJ; Brew BJ, 2004, 'Phenotypic differences and similarities between microglia, macrophage and pericyte (review)', Journal of Leukocyte Biology, vol. 75, pp. 388 - 397

Cysique LA; Maruff P; Brew BJ, 2004, 'Prevalence and pattern of neuropsychological impairment in humanimmunodeficiency virus-infected/acquired immunodeficiency syndrome(HIV/AIDS) patients across pre- and post-highly active antiretroviraltherapy eras: A combined study of two cohorts', Journal of Neurovirology, vol. 10, pp. 350 - 357, http://dx.doi.org/10.1080/13550280490521078

Cysique LA; Maruff P; Brew BJ, 2004, 'Antiretroviral therapy in HIV infection: are neurologically active drugs important?', Archives of Neurology, vol. 61, pp. 1699 - 1704, http://dx.doi.org/10.1001/archneur.61.11.1699

Newell ME; Hoy JF; Cooper S; De Graaff B; Grulich AE; Bryant M; Millar JL; Brew BJ; Quinn DI, 2004, 'Human immunodeficiency virus-related primary central nervous system lymphoma: factors influencing survival in 111 patients', Cancer, vol. 100, pp. 2627 - 2636, http://dx.doi.org/10.1002/cncr.20300

Guillemin GJ; Brew BJ, 2004, 'Microglia, macrophages, perivascular macrophages, and pericytes: a review of function and identification', Journal of Leukocyte Biology, vol. 75, pp. 388 - 397, http://dx.doi.org/10.1189/jlb.0303114

Brew BJ; Pemberton LA; Ray J, 2004, 'Can the peripheral blood monocyte count be used as a marker of CSF resistance to antiretroviral drugs?', Journal of Neurovirology, vol. 10 Suppl 1, pp. 38 - 43

Brew BJ, 2004, 'Evidence for a change in AIDS dementia complex in the era of highly active antiretroviral therapy and the possibility of new forms of AIDS dementia complex', AIDS, vol. 18 Suppl 1, pp. S75 - S78

Brew BJ; Tomlinson SE, 2004, 'HIV neuropathy: time for new therapies', Drug Discovery Today-Disease Models, vol. 1, pp. 171 - 176, http://dx.doi.org/10.1016/j.ddmod.2004.09.012

Smit T; Brew BJ; Tourtellotte W; Morgello S; Gelman B; Saksena NK, 2004, 'Independent evolution of human immunodeficiency virus (HIV) drugresistance mutations in diverse areas of the brain in HIV-infectedpatients, with and without dementia, on antiretroviral treatment', Journal of Virology, vol. 78, pp. 10133 - 10148, http://dx.doi.org/10.1128/JVI.78.18.10133-10148.2004

Brew BJ, 2004, 'Evidence for a change in AIDS dementia complex in the era of highly active antiretroviral therapy and the possibility of new forms of AIDS dementia complex', AIDS, pp. 75 - 78, http://dx.doi.org/10.1097/00002030-200418001-00011

Guillemin GJ; Croitoru-Lamoury J; Dormont D; Armati PJ; Brew BJ, 2003, 'Quinolinic acid upregulates chemokine production and chemokine receptor expression in astrocytes', GLIA, vol. 41, pp. 371 - 381, http://dx.doi.org/10.1002/glia.10175

Guillemin GJ; Smythe GA; Veas LA; Takikawa O; Brew BJ, 2003, 'A1-42 induces production of quinolinic acid by human macrophages and microglia', NeuroReport, vol. 14, pp. 165 - 181

Guillemin GJ; Croitoru J; Dormont J; Armati PJ; Brew BJ, 2003, 'Quinolinic acid upregulates chemokine production and chemokine receptor expression in astrocytes: implications for brain inflammation in AIDS', Glia, vol. 41, pp. 371 - 381

Brew BJ; Tisch S; Law MG, 2003, 'HIV nucleoside neuropathy and HIV distal symmetrical neuropathy: relationships to serum lactate and plasma HIV viral load', AIDS, vol. 17, pp. 1094 - 1096

Guillemin GJ; Williams K; Smith DG; Smythe GA; Croitoru-Lamoury J; Brew BJ, 2003, 'Quinolinic acid in the pathogenesis of Alzheimer`s disease', Advances in Experimental Medicine and Biology, vol. 527, pp. 167 - 176, http://www.springer.com/series/5584

Guillemin GJ; Smythe GA; Veas LA; Takikawa O; Brew BJ, 2003, 'A beta I-42 induces production of quinolinic acid by human macrophagesand microglia', Neuroreport, vol. 14, pp. 2311 - 2315

Guillemin GJ; Croitoru-Lamoury J; Dormont D; Brew BJ, 2003, 'Involvement of quinolinic acid in chemokine production and chemokine receptor expression in human foetal astrocytes', Advances in Experimental Medicine and Biology, vol. 527, pp. 37 - 45

Guillemin GJ; Smith DG; Armati PJ; Brew BJ, 2003, 'Expression kynurenine pathway enzymes in human macrophages and microglia', Advances in Experimental Medicine and Biology, vol. 527, pp. 105 - 112

Guillemin GJ; Croitoru J; Dormont D; Armati PJ; Brew BJ, 2003, 'Involvement of quinolinic acid in chemokine production and chemokine receptor expression in human fœtal astrocytes', Glia, vol. 41, pp. 371 - 381

Dore GJ; McDonald AM; Li Y; Kaldor JM; Brew BJ, 2003, 'Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy', AIDS, vol. 17, pp. 1539 - 1545, http://dx.doi.org/10.1097/00002030-200307040-00015

Guillemin GJ; Smith DG; Williams KR; Smythe GA; Dormont D; Brew BJ, 2003, 'Quinolinic acid in the pathogenesis of Alzheimer’s disease', Advances in Experimental Medicine and Biology, vol. 527, pp. 167 - 176

Guillemin GJ; Smith DG; Smythe GA; Armati PJ; Brew BJ, 2003, 'Expression of the kynurenine pathway enzymes in human microglia and macrophages', Advances in Experimental Medicine and Biology, vol. 527, pp. 105 - 112

Croitoru-Lamoury J; Guillemin GJ; Dormont D; Brew BJ, 2003, 'Quinolinic acid up-regulates chemokine production and chemokinereceptor expression in astrocytes', Advances in Experimental Medicine and Biology, vol. 527, pp. 37 - 45

Brew BJ, 2003, 'The peripheral nerve complications of human immunodeficiency virus (HIV) infection', Muscle and Nerve, vol. 28, pp. 542 - 552, http://dx.doi.org/10.1002/mus.10484

Croitoru J; Guillemin GJ; Boussin F; Mognetti B; Gigout LI; Cheret A; Vaslin A; Le Grand AR; Brew BJ; Dormont J, 2003, 'Expressions of chemokines and their receptors in human and simian astrocytes: evidence for a central effect of TNF and IFN in CXCR4 and CCR5 modulation.', Glia, vol. 41, pp. 354 - 370, http://dx.doi.org/10.1002/glia.10181

Guillemin GJ; Smythe GA; Veas LA; Takikawa O; Brew BJ, 2003, 'ABeta 1-42 Induces Production of Quinolinic Acid by Human Macrophases and Microglia.', Neuroreport, vol. 14, pp. 2311 - 2315, http://dx.doi.org/10.1097/00001756-200312190-00005

Brew BJ; Tisch S; Law MG, 2003, 'Lactate concentrations distinguish between nucleoside neuropathy and HIV neuropathy', AIDS, vol. 17, pp. 1094 - 1096, http://dx.doi.org/10.1097/00002030-200305020-00024

Guillemin GJ; Brew BJ, 2002, 'Implications of the kynurenine pathway and quinolinic acid in Alzheimer's disease', Redox Report, vol. 7, pp. 199 - 206, http://dx.doi.org/10.1179/135100002125000550

Bain M; Brew B; Coltheart M, 2002, 'Progressive peripheral dysgraphia in early posterior cortical atrophy', NEUROBIOLOGY OF AGING, vol. 23, pp. S39 - S40, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000177465300149&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Loy CT; Brew BJ, 2002, 'Treatment of opportunistic infections and lymphoma in the nervous system.', Journal of HIV therapy, vol. 7, pp. 21 - 25

Guillemin GJ; Brew BJ, 2002, 'Implications of the kynurenine pathway and quinolinic acid in Alzheimer`s disease', Redox Report, vol. 7, pp. 1

Loy C; Brew BJ, 2002, 'Lymphona and opportunistic infections of the brain', Journal of Hiv Therapy, vol. 7, pp. 21 - 25

Smythe GA; Braga O; Brew BJ; Grant RS; Guillemin GJ; Kerr SJ; Walker DW, 2002, 'Concurrent quantification of quinolinic, picolinic and nicotinic acids using electron-capture negative-ion gas chromatography-mass spectrometry', Analytical Biochemistry, vol. 301, pp. 21 - 26, http://dx.doi.org/10.1006/abio.2001.5490

Brew BJ, 2001, 'HTLV-I and HIV infections of the CNS in tropical areas [10]', Journal of Neurology Neurosurgery and Psychiatry, vol. 70, pp. 138, http://dx.doi.org/10.1136/jnnp.70.1.138

Guillemin GJ; Kerr SJ; Smythe GA; Smith DG; Kapoor V; Armati PJ; Croitoru J; Brew BJ, 2001, 'Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection', Journal of Neurochemistry, vol. 78, pp. 842 - 853, http://dx.doi.org/10.1046/j.1471-4159.2001.00498.x

Brew BJ, 2001, 'Markers of AIDS dementia complex: the role of cerebrospinal fluid assays', AIDS, vol. 15, pp. 1883 - 1884, http://dx.doi.org/10.1097/00002030-200109280-00020

Guillemin GJ; Kerr SJ; Pemberton LA; Smith DG; Smythe GA; Armati PJ; Brew BJ, 2001, 'IFN-b1b induces Kynurenine pathway metabolism in human macrophages:potential implications for multiple sclerosis treatment', Journal of Interferon and Cytokine Research, vol. 21, pp. 1097 - 1101, http://dx.doi.org/10.1089/107999001317205231

Smith DG; Guillemin GJ; Pemberton LA; Kerr SJ; Nath A; Smythe GA; Brew BJ, 2001, 'Quinolinic acid is produced by macrophages stimulated by platelet activating factor, NeF and Tat', Journal of Neurovirology, vol. 7, pp. 56 - 60, http://dx.doi.org/10.1080/135502801300069692

Pemberton LA; Brew BJ, 2001, 'Cerebrospinal fluid S-100ß and its relationship with AIDS dementia complex.', Journal of Clinical Virology, vol. 22, pp. 249 - 253, http://dx.doi.org/10.1016/S1386-6532(01)00196-2

Lanier ER; Sturge G; McClernon D; Brown S; Halman M; Sacktor N; McArthur J; Atkinson JH; Clifford D; Price R; Simpson D; Torres G; Catalan J; Marder K; Power C; Hall C; Romero C; Brew BJ, 2001, 'HIV-1 reverse transcriptase sequence in plasma and cerebrospinal fluid of patients with AIDS dementia complex treated with abacavir', AIDS, vol. 15, pp. 747 - 751, http://dx.doi.org/10.1097/00002030-200104130-00010

Smit T; Wang B; Ng T; Osborne R; Brew BJ; Saksena NK, 2001, 'Varied tropism of HIV-1 isolates derived from different regions of adult brain cortex discriminate between patients with and without AIDS Dementia Complex (ADC): evidence for neurotropic HIV variants.', Virology, vol. 279, pp. 509 - 526, http://dx.doi.org/10.1006/viro.2000.0681

Guillemin GJ; Smith DD; Kerr SJ; Smythe GA; Kapoor V; Armati P; Brew BJ, 2000, 'Characterisation of kynurenine pathway metabolism in human astrocytes and implications in neutopathogenesis', Redox Report, pp. 108 - 111

Cunningham PH; Smith DD; Satchell C; Cooper DA; Brew BJ, 2000, 'Evidence for independent development of resistance to HIV-1 reverse transcriptase inhibitors in the cerebrospinal fluid.', AIDS, vol. 14, pp. 1949 - 1954, http://dx.doi.org/10.1097/00002030-200009080-00010

Guillemin GJ; Smith DG; Kerr SJ; Smythe GA; Kapoor V; Armati P; Brew BJ, 2000, 'Characterisation of kynurenine pathway metabolism in human astrocytes and implications in neuropathogenesis', Redox Report, vol. 5, pp. 108 - 111, http://dx.doi.org/10.1179/135100000101535375

Grulich AE; Dore GJ; Brew BJ, 2000, 'Human herpesvirus 8 and protection from AIDS dementia complex', Herpes, vol. 7, pp. 38 - 40

Dore GJ; Brew BJ, 2000, 'Response to Eberly et al., Kaposi¿s sarcoma and central nervous system disease: a real association or an artifact of the control group? (letter)', AIDS, vol. 14, pp. 2631 - 2632, http://dx.doi.org/10.1097/00002030-200011100-00037

Brew BJ; Dore GJ, 2000, 'Decreasing incidence of CNS AIDS defining events associated with antiretroviral therapy (letter)', Neurology, vol. 55, pp. 1424 - 1424, http://dx.doi.org/10.1212/WNL.55.9.1424

Brew BJ, 2000, 'Does HHV-8 have a neuroprotective role on the development of HIV encephalopathy? (letter)', Neurology, vol. 55, pp. 459 - 460, http://dx.doi.org/10.1212/WNL.55.3.459-a

Dore GJ; Correll PK; Li Y; Kaldor JM; Cooper DA; Brew BJ, 1999, 'Changes to AIDS dementia complex in the era of highly active antiretroviral therapy', AIDS, vol. 13, pp. 1249 - 1253, http://dx.doi.org/10.1097/00002030-199907090-00015

Guillemin GJ; Kerr SJ; Smythe GA; Armati P; Brew BJ, 1999, 'Kynurenine pathway metabolism in human astrocytes', Advances in Experimental Medicine and Biology, vol. 467, pp. 125 - 131

Brennan JD; Pell MF; Brew BJ, 1999, 'HIV-related primary cerebral lymphoma: the role of stereotactic biopsy', Journal of Clinical Neuroscience, vol. 6, pp. 217 - 220, http://dx.doi.org/10.1016/S0967-5868(99)90506-4

Brew BJ, 1999, 'AIDS dementia complex', Neurologic Clinics, vol. 17, pp. 861 - 881, http://dx.doi.org/10.1016/S0733-8619(05)70170-5

Brew BJ; Gisslen M; Svennerholm B; Fuchs D; Hagberg L, 1998, 'Neurological efficacy of stavudine, zidovudine, and lamivudine (multiple letters) [2]', Lancet, vol. 352, pp. 402 - 403, http://dx.doi.org/10.1016/s0140-6736(05)60498-9

Kerr SJ; Pemberton LA; Guillemin GJ; Smythe G; Brew BJ, 1998, 'Interferon-beta induces kynurenine pathway metabolism inhuman macrophages', NEUROLOGY, vol. 50, pp. A34 - A34, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000073240900095&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Mcphee D; Greenway AL; Holloway G; Smith KR; Deacon N; Pemberton LA; Brew BJ, 1998, 'Anomalies in Nef expression within the central nervous system of HIV-1 positive individuals/AIDS patients with or without AIDS dementia complex', Journal of Neurovirology, vol. 4, pp. 291 - 300, http://dx.doi.org/10.3109/13550289809114530

Markus R; Brew BJ, 1998, 'HIV-1 peripheral neuropathy and combination antiretroviral therapy', Lancet, vol. 352, pp. 1906 - 1907, http://dx.doi.org/10.1016/S0140-6736(05)60397-2

Kerr SJ; Amarti PJ; Guilbaud G; Brew BJ, 1998, 'Chronic exposure of human neurons to quinolinic acid results in neuronal changes consistent with AIDS dementia complex', AIDS, vol. 12, pp. 355 - 363, http://dx.doi.org/10.1097/00002030-199804000-00003

Szeto ER; Freund J; Brew BJ; Loder A; Griffiths M, 1998, 'Cerebral perfusion scanning in treating AIDS dementia', Journal of Nuclear Medicine, vol. 39, pp. 298 - 302

Brew BJ, 1998, 'Neurological efficacy of stavudine, zidovudine, and lamivudine', Lancet, vol. 352, pp. 402 - 402, http://dx.doi.org/10.1016/S0140-6736(05)60498-9

Dore GJ; Grulich AE; Law MG; Brew BJ; Kaldor JM, 1998, 'Kaposi¿s sarcoma and protection from AIDS dementia complex', AIDS, vol. 12, pp. 2354 - 2355

Brew BJ, 1998, 'Evaluation and management of intracranial mass lesions in AIDS - Report of the Quality Standards Subcommittee of the American Academy of Neurology', Neurology, vol. 51, pp. 1232 - 1233

Bradley TP; Brew BJ, 1997, 'HIV type-1-related transient neurologic deficits [2] (multiple letters)', American Journal of Medicine, vol. 103, pp. 250

Brew BJ, 1997, 'HIV type-1-related transient neurologic deficits - Reply', AMERICAN JOURNAL OF MEDICINE, vol. 103, pp. 250 - 251, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1997XX32200012&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Johnson DW; Brew BK; Poronnik P; Cook DI; Field MJ; Gyory AZ; Pollock CA, 1997, 'Insulin-like growth factor I stimulates apical sodium/hydrogen exchange in human proximal tubule cells', AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, vol. 272, pp. F484 - F490, http://dx.doi.org/10.1152/ajprenal.1997.272.4.F484

Dunbar N; Pemberton L; Perdices M; Brew BJ, 1997, 'Clinical markers of the presence of dementia and neuropsychological impairment in hiv infection', Journal of Neuro-AIDS, vol. 1, pp. 31 - 48, http://dx.doi.org/10.1300/J128v01n04_04

Dore GJ; Law MG; Brew BJ, 1997, 'Prospective analysis of seizures occurring in human immunodeficiency virus type-1 infection', Journal of Neuro-AIDS, vol. 1, pp. 59 - 69, http://dx.doi.org/10.1300/J128v01n04_06

Kerr SJ; Armati PJ; Pemberton LA; Smythe G; Brew BJ, 1997, 'Kynurenine pathway inhibition with 6-chloro-D-tryptophan reduces neurotoxicity of HIV-1 infected macrophage supernatants', NEUROLOGY, vol. 48, pp. 2008 - 2008, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1997XG87100226&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Brew BJ, 1997, 'The cellular basis of central nervous HIV-1 infection and the AIDS dementia complex - Price,RW, Sidtis,JJ', VENEREOLOGY-THE INTERDISCIPLINARY INTERNATIONAL JOURNAL OF SEXUAL HEALTH, vol. 10, pp. 126 - 126, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1997XV34400011&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Dunbar N; Brew B, 1997, 'Neuropsychological Dysfunction in HIV Infection:A Review', Journal of neuro-AIDS, vol. 1, pp. 73 - 102

Pemberton LA; Kerr SJ; Smythe GA; Brew BJ, 1997, 'Quinolinic acid production by macrophages stimulate with interferon y tumour necrosis factor a and interferon a', Journal of Interferon and Cytokine Research, vol. 17, pp. 589 - 595

Pemberton LA; Kerr SJ; Smythe GA; Brew BJ, 1997, 'Quinolinic acid production by macrophages stimulated with IFN-gamma, TNF-alpha, and IFN-alpha', Journal of Interferon and Cytokine Research, vol. 17, pp. 589 - 595, http://dx.doi.org/10.1089/jir.1997.17.589

Adcock JE; Davies MJ; Turner J; Pell MF; Brew BJ, 1997, 'Progressive multifocal leukoencephalopathy: a retrospective study of 30 cases', Journal of Clinical Neuroscience, vol. 4, pp. 463 - 468, http://dx.doi.org/10.1016/S0967-5868(97)90036-9

Kerr SJ; Armati P; Pemberton LA; Smythe GA; Tattam B; Brew BJ, 1997, 'Kynurenine pathway inhibition reduces neurotoxicity of HIV-1-infected macrophages', Neurology, vol. 49, pp. 1671 - 1681, http://dx.doi.org/10.1212/WNL.49.6.1671

Cunningham AL; Naif H; Saksena N; Lynch G; Chang JW; Li S; Jozwiak R; Alali M; Wang B; Fear W; Sloane A; Pemberton LA; Brew BJ, 1997, 'HIV infection of macrophages and the pathogenesis of AIDS dementia complex: interaction of the host cell and viral genotype', Journal of Leukocyte Biology, vol. 62, pp. 117 - 125, http://dx.doi.org/10.1002/jlb.62.1.117

Brew BJ; Pemberton LA; Cunningham PH; Law MG, 1997, 'Levels of human imunodeficiency virus type RNA in cerebrospinal fluid correlae with AIDS dementia stage', Journal of Infectious Diseases, vol. 175, pp. 963 - 966, http://dx.doi.org/10.1086/514001

Dick AD; Pell MF; Brew BJ; Foulcher E; Sedgwick JD, 1997, 'Direct ex vivo flow cytometric analysis of human microglial cell CD4 expression: examination of central nervous system biopsy specimens from HIV-seropositive patients and patients with other neurological disease', AIDS, vol. 11, pp. 1699 - 1708, http://dx.doi.org/10.1097/00002030-199714000-00006

Markus R; Brew BJ; Turner J; Pell MF, 1997, 'Successful outcome with aggressive treatment of acute haemorrhagic leukoencephalitis', Journal of Neurology Neurosurgery and Psychiatry, vol. 63, pp. 551 - 551, http://dx.doi.org/10.1136/jnnp.63.4.551

Pemberton LA; Kerr SJ; Brew BJ, 1997, 'HIV-1 gp120 does not induce quinolinic acid production by macrophages', Journal of Neurovirology, vol. 3, pp. 86 - 87, http://dx.doi.org/10.3109/13550289709015798

Dunbar N; Brew B, 1996, 'Neuropsychological dysfunction in HIV infection: A review', Journal of Neuro-AIDS, vol. 1, pp. 73 - 102, http://dx.doi.org/10.1300/J128v01n03_05

Brew BJ; Glass JD; McArthur JC, 1996, 'Human immunodeficiency virus in brain and correlation with dementia [5]', Annals of Neurology, vol. 39, pp. 828 - 829, http://dx.doi.org/10.1002/ana.410390631

Wright EJ; Brew BJ; Currie JN; McArthur JC, 1996, '5.4 HIV-induced neurological disease', Medical Journal of Australia, vol. 164, pp. 414 - 417, http://dx.doi.org/10.5694/j.1326-5377.1996.tb122090.x

Wright EJ; Brew BJ; Currie JN; McArthur JC, 1996, 'Managing HIV .5. Treating secondary outcomes - HIV-induced neurological disease', MEDICAL JOURNAL OF AUSTRALIA, vol. 164, pp. 414 - 417, http://dx.doi.org/10.5694/j.1326-5377.1996.tb122090.x

Jones PD; Beaman MH; Brew BJ, 1996, 'Managing HIV .5. Treating secondary outcomes - HIV and opportunistic neurological infections', MEDICAL JOURNAL OF AUSTRALIA, vol. 164, pp. 418 - 421, http://dx.doi.org/10.5694/j.1326-5377.1996.tb122091.x

Jones PD; Beaman MH; Brew BJ, 1996, '5.5 HIV and opportunistic neurological infections', Medical Journal of Australia, vol. 164, pp. 418 - 421, http://dx.doi.org/10.5694/j.1326-5377.1996.tb122091.x

Brew BJ; Wesselingh SL; Gonzales M; Heyes MP; Price RW, 1996, 'Managing HIV. Part 3: Mechanisms of diseases. 3.7 How HIV leads to neurological disease.', Med J Aust, vol. 164, pp. 233 - 234, https://www.ncbi.nlm.nih.gov/pubmed/8604196

Brew BJ; Wesselingh SL; Gonzales M; Heyes MP; Price RW, 1996, 'How HIV leads to neurological disease', Medical Journal of Australia, vol. 164, pp. 233 - 234, http://dx.doi.org/10.5694/j.1326-5377.1996.tb94148.x

Norton GR; Sweeney J; Marriott D; Law MG; Brew BJ, 1996, 'Association between HIV distal symmetric polyneuropathy and Mycobacterium avium complex infection', Journal of Neurology Neurosurgery and Psychiatry, vol. 61, pp. 606 - 609, http://dx.doi.org/10.1136/jnnp.61.6.606

Norton GR; Sweeney J; Marriott D; Law MG; Brew BJ, 1996, 'An association between HIV distal symmetrical polyneuropathy and Mycobacterium Avium complex infection', Journal of Neurology Neurosurgery and Psychiatry, pp. 606 - 609

Brew BJ; Corbeil J; Pemberton LA; Evans L; Saito K; Penny R; Cooper DA; Heyes MP, 1996, 'Quinolinic acid production by macrophages infected with HIV-1 isolates from patients with and without AIDS dementia complex', Journal of Neurovirology, vol. 1, pp. 369 - 374

Brew BJ; Dunbar N; Druett J; Freund J; Ward PB, 1996, 'Pilot study of the efficacy of atervidine in ADC', AIDS, vol. 10, pp. 1357 - 1360

Brew BJ; Evans L; Byrne C; Pemberton LA; Hurren L, 1996, 'The relationship between AIDS demtia complex and the presence of macriphage tropic and non syncytium inducing isolates of human immunodeficiency virus type 1 in the cerebrospinal fluid', Journal of Neurovirology, vol. 2, pp. 152 - 157, http://dx.doi.org/10.3109/13550289609146877

Field AS; Marriot DJ; Milliken ST; Brew BJ; Canning EU; Kench JG; Darveniza P; Harkness JL, 1996, 'Myositis associated with a newly describes microsporidian Trachipleistophora hominis, in a patient with AIDS', Journal of Clinical Microbiology, vol. 34, pp. 2803 - 2811

Brew BJ; Dunbar N; Druett J; Freund J; Ward PB, 1996, 'Pilot study of the efficacy of atevirdine in the treatment of AIDS dementia complex', AIDS, vol. 10, pp. 1357 - 1360, http://dx.doi.org/10.1097/00002030-199610000-00007

Brew BJ; Miller J, 1996, 'Human immunodeficiency virus type 1 related transient neurologic deficits', American Journal of Medicine, vol. 101, pp. 257 - 261, http://dx.doi.org/10.1016/S0002-9343(96)00123-4

Kerr SJ; Armati P; Brew BJ, 1996, 'Neurocytotoxicity of quinolinic acid in human brain cultures', Journal of Neurovirology, vol. 1, pp. 375 - 380, http://dx.doi.org/10.3109/13550289509111027

Brew BJ; Corbeil J; Pemberton L; Evans L; Saito K; Penny R; Cooper DA; Heyes MP, 1995, 'Quinolinic acid production is related to macrophage tropic isolates of HIV-1.', Journal of neurovirology, vol. 1, pp. 369 - 374, http://dx.doi.org/10.3109/13550289509111026

Brew BJ; Rosenblum M; Cronin K; Price RW, 1995, 'AIDS dementia complex and HIV‐1 brain infection: Clinical‐virological correlations', Annals of Neurology, vol. 38, pp. 563 - 570, http://dx.doi.org/10.1002/ana.410380404

Davies MA; Pell MF; Brew BJ, 1995, 'Stereotactic biopsy of cerebral lesions in acquired immunodeficiency syndrome', Journal of Clinical Neuroscience, vol. 2, pp. 40 - 44, http://dx.doi.org/10.1016/0967-5868(95)90028-4

Brew BJ; Rosenblum M; Cronin K; Price R, 1995, 'The AIDS dementia complex and human immunodeficiency virus type 1 brian infection: clinical-virological correlations', Annals of Neurology, pp. 563 - 570

Davies MJ; Pell MF; Brew BJ, 1995, 'Stereotectic biopsy of cerebral lesions in AIDS', Journal of Clinical Neuroscience, vol. 2, pp. 40 - 44

Davies MJ; Pell MF; Brew BJ, 1995, 'Stereotactic biopsy of cerebral lesions in AIDS', Journal of Clinical Neuroscience, vol. 2, pp. 40 - 44

Dick AD; Pell M; Brew BJ; Sedgwick JD, 1995, 'Flow cytometric phenotyping of freshly isolated, human CNS microglia reveals increased CD4 expression in HIV-infected individuals', Journal of Neuroimmunology, vol. 63, pp. 99 - 99, http://dx.doi.org/10.1016/0165-5728(96)80983-0

Clezy K; Sirisanthana T; Sirisanthana V; Brew B; Cooper DA, 1994, 'Late manifestations of HIV in Asia and the Pacific', AIDS, vol. 8

Kelleher AD; Brew BJ; Milliken ST, 1994, 'Intractable headache as the presenting complaint of AIDS-related lymphoma confined to bone', Journal of Acquired Immune Deficiency Syndromes, vol. 7, pp. 629 - 630

Milstien S; Sakai N; Brew BJ; Krieger C; Vickers JH; Saito K; Heyes MP, 1994, 'Cerebrospinal fluid nitrite/nitrate levels in neurologic diseases', Journal of Neurochemistry, vol. 63, pp. 1178 - 1180, http://dx.doi.org/10.1046/j.1471-4159.1994.63031178.x

Brew BJ, 1994, 'The clinical spectrum and pathogenesis of HIV encephalopathy, myelopathy, and peripheral neuropathy', Current Opinion in Neurology, vol. 7, pp. 209 - 216, http://dx.doi.org/10.1097/00019052-199406000-00006

Brew BJ, 1994, 'HIV dementia', Neurology, vol. 44, pp. 2214, http://dx.doi.org/10.1212/wnl.44.11.2214-a

Brew BJ; Paul MO; Nakajima G; Khan A; Gallardo H; Price RW, 1994, 'Cerebrospinal fluid HIV-1 p24 antigen and culture: Sensitivity and specificity for AIDS-dementia complex', Journal of Neurology, Neurosurgery and Psychiatry, vol. 57, pp. 784 - 789, http://dx.doi.org/10.1136/jnnp.57.7.784

Brew BJ, 1994, 'Optimal Treatment of HIV-1-Induced CNS Neurological Disorders', CNS Drugs, vol. 2, pp. 292 - 300, http://dx.doi.org/10.2165/00023210-199402040-00005

Brew B, 1994, 'HIV, AIDS and the brain', Journal of Clinical Neuroscience, vol. 1, pp. 213 - 214, http://dx.doi.org/10.1016/0967-5868(94)90056-6

Quinn D; Pocock N; Freund J; Kelleher A; Penny R; Brew B, 1993, 'Radionuclide hepatobiliary scanning in patients with AIDS-related sclerosing cholangitis', Clinical Nuclear Medicine, vol. 18, pp. 417 - 422, http://dx.doi.org/10.1097/00003072-199305000-00010

BREW BJ; CURRIE JN, 1993, 'COULD IT BE HIV .8. HIV-RELATED NEUROLOGICAL DISEASE', MEDICAL JOURNAL OF AUSTRALIA, vol. 158, pp. 104 - 108, http://dx.doi.org/10.5694/j.1326-5377.1993.tb137536.x

Brew BJ; Currie JN, 1993, 'HIV-related neurological disease', Medical Journal of Australia, vol. 158, pp. 104 - 108, http://dx.doi.org/10.5694/j.1326-5377.1993.tb137536.x

Brew BJ; Miller J, 1993, 'Human immunodeficiency virus-related headache', Neurology, vol. 43, pp. 1098 - 1100, http://dx.doi.org/10.1212/wnl.43.6.1098

Brew BJ, 1993, 'The pathogenesis of the neurological complications of HIV-1 infection', Genitourinary Medicine, vol. 69, pp. 333 - 340, http://dx.doi.org/10.1136/sti.69.5.333

Shaskan EG; Brew BJ; Rosenblum M; Thompson RM; Price RW, 1992, 'Increased Neopterin Levels in Brains of Patients with Human Immunodeficiency Virus Type 1 Infection', Journal of Neurochemistry, vol. 59, pp. 1541 - 1546, http://dx.doi.org/10.1111/j.1471-4159.1992.tb08471.x

Carr A; Tindall B; Brew BJ; Marriott DJ; Harkness JL; Penny R; Cooper DA, 1992, 'Low-dose trimethoprim-sulfamethoxazole prophylaxis for toxoplasmic encephalitis in patients with AIDS', Annals of Internal Medicine, vol. 117, pp. 106 - 111, http://dx.doi.org/10.7326/0003-4819-117-2-106

Rosenblum MK; Brew BJ; Hahn B; Shaw G; Haase A; Maroushek S; Price RW, 1992, 'Human T-lymphotropic virus type I-associated myelopathy in patients with the acquired immunodeficiency syndrome', Human Pathology, vol. 23, pp. 513 - 519, http://dx.doi.org/10.1016/0046-8177(92)90128-P

Brew BJ; Bhalla RB; Paul M; Sidtis JJ; Keilp JJ; Sadler AE; Gallardo H; McArthur JC; Schwartz MK; Price RW, 1992, 'Cerebrospinal fluid β2-microglobulin in patients with AIDS dementia complex: An expanded series including response to zidovudine treatment', AIDS, vol. 6, pp. 461 - 465, http://dx.doi.org/10.1097/00002030-199205000-00004

Heyes MP; Brew BJ; Saito K; Quearry BJ; Price RW; Lee K; Bhalla RB; Der M; Markey SP, 1992, 'Inter-relationships between quinolinic acid, neuroactive kynurenines, neopterin and β2-microglobulin in cerebrospinal fluid and serum of HIV-1-infected patients', Journal of Neuroimmunology, vol. 40, pp. 71 - 80, http://dx.doi.org/10.1016/0165-5728(92)90214-6

Brew BJ, 1992, 'Central and peripheral nervous system abnormalities', Medical Clinics of North America, vol. 76, pp. 63 - 81, http://dx.doi.org/10.1016/S0025-7125(16)30371-6

Brew BJ; Perdices M, 1992, 'HIV nomenclature', Neurology, vol. 42, pp. 265, http://dx.doi.org/10.1212/WNL.42.1.265

Brew BJ, 1992, 'Medical management of AIDS patients. Central and peripheral nervous system abnormalities.', Med Clin North Am, vol. 76, pp. 63 - 81, http://dx.doi.org/10.1016/s0025-7125(16)30371-6

Reimund E; Martin AA; Emerich DF; Sanberg PR; James Brew B; Everall I; Luthert P; Lantos P, 1991, 'Neuronal loss in frontal cortex in HIV infection', The Lancet, vol. 338, pp. 129 - 130, http://dx.doi.org/10.1016/0140-6736(91)90131-8

KAPLAN JE; LITCHFIELD B; ROUAULT C; LAIRMORE MD; LUO CC; WILLIAMS L; BREW BJ; PRICE RW; JANSSEN R; STONEBURNER R; OU CY; FOLKS T; DE B, 1991, 'HTLV-I ASSOCIATED MYELOPATHY ASSOCIATED WITH BLOOD-TRANSFUSION IN THE UNITED-STATES - EPIDEMIOLOGIC AND MOLECULAR EVIDENCE LINKING DONOR AND RECIPIENT', NEUROLOGY, vol. 41, pp. 192 - 197, http://dx.doi.org/10.1212/WNL.41.2_Part_1.192

Brew BJ; Cooper DA, 1991, 'Neurological manifestations of HIV-1 infection [10]', AIDS, vol. 5, pp. 609, http://dx.doi.org/10.1097/00002030-199105000-00030

Price RW; Sidtis JJ; Brew BJ, 1991, 'AIDS Dementia Complex and HIV‐1 Infection: A View From the Clinic', Brain Pathology, vol. 1, pp. 155 - 162, http://dx.doi.org/10.1111/j.1750-3639.1991.tb00655.x

Portegies P; Brew BJ, 1991, 'Update on HIV-related neurological illness.', AIDS (London, England), vol. 5 Suppl 2, http://dx.doi.org/10.1097/00002030-199101001-00029

Heyes MP; Brew B; Martin A; Markey SP; Price RW; Bhalla RB; Salazar A, 1991, 'Cerebrospinal fluid quinolinic acid concentrations are increased in acquired immune deficiency syndrome', Advances in Experimental Medicine and Biology, vol. 294, pp. 687 - 690, http://dx.doi.org/10.1007/978-1-4684-5952-4_94

Brew BJ, 1991, 'MS-like leukoencephalopathy in HIV-1', Neurology, vol. 41, pp. 1166, http://dx.doi.org/10.1212/WNL.41.7.1166-a

Heyes MP; Brew BJ; Martin A; Price RW; Salazar AM; Sidtis JJ; Yergey JA; Mouradian MM; Sadler AE; Keilp J; Rubinow D; Markey SP, 1991, 'Quinolinic acid in cerebrospinal fluid and serum in HIV‐1 Infection: Relationship to clinical and neurological status', Annals of Neurology, vol. 29, pp. 202 - 209, http://dx.doi.org/10.1002/ana.410290215

Janssen RS; Kaplan JE; Khabbaz RF; Hammond R; Lechtenberg R; Lairmore M; Chiasson MA; Punsalang A; Roberts B; Mc Kendall RR; Rosenblum M; Brew B; Farraye J; Howley DJ; Feraru E; Sparr S; Vecchio J; Silverman M; Mc Harg M; Gorin B; Rugg DR; Grenell S; Trimble B; Bruining K; Guha S; Amaraneni P; Price RW, 1991, 'HTLV–I—associated myelopathy/tropical spastic paraparesis in the United States', Neurology, vol. 41, pp. 1355 - 1357, http://dx.doi.org/10.1212/wnl.41.9.1355

Kaplan JE; Litchfield B; Rouault C; Lairmore MD; Luo CC; Williams L; Brew BJ; Price RW; Janssen R; Stoneburner R; Ou CY; Folks T; De B, 1991, 'HTLV-I—associated myelopathy associated with blood transfusion in the United States: Epidemiologic and molecular evidence linking donor and recipient', Neurology, vol. 41, pp. 192 - 197, http://dx.doi.org/10.1212/wnl.41.2_part_1.192

Kaplan JE; Litchfield B; Rouault C; Lairmore MD; Luo CC; Williams L; Brew BJ; Price RW; Janssen R; Stoneburner R, 1991, 'HTLV-I-associated myelopathy associated with blood transfusion in the United States: epidemiologic and molecular evidence linking donor and recipient.', Neurology, vol. 41, pp. 192 - 197, http://dx.doi.org/10.1212/wnl.41.2_part_1.192

BREW BJ, 1990, 'REPLY', Australian and New Zealand Journal of Medicine, vol. 20, pp. 630 - 630, http://dx.doi.org/10.1111/j.1445-5994.1990.tb01333.x

BREW BJ, 1990, 'Prognosis of patients … myelopathy of unknown origin', Australian and New Zealand Journal of Medicine, vol. 20, pp. 189 - 189, http://dx.doi.org/10.1111/j.1445-5994.1990.tb01303.x

Price RW; Brew BJ; Rosenblum M, 1990, 'The AIDS dementia complex and HIV-1 brain infection: a pathogenetic model of virus-immune interaction.', Research publications - Association for Research in Nervous and Mental Disease, vol. 68, pp. 269 - 290

Krown SE; Gold JWM; Niedzwiecki D; Bundow D; Flomenberg N; Gansbacher B; Brew BJ, 1990, 'Interferon-α with zidovudine: Safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS)', Annals of Internal Medicine, vol. 112, pp. 812 - 821, http://dx.doi.org/10.7326/0003-4819-112-11-812

Brew BJ; Bhalla RB; Paul M; Gallardo H; McArthur JC; Schwartz MK; Price RW, 1990, 'Cerebrospinal fluid neopterin in human immunodeficiency virus type 1 infection', Annals of Neurology, vol. 28, pp. 556 - 560, http://dx.doi.org/10.1002/ana.410280413

BREW BJ; PERDICES M; DARVENIZA P; EDWARDS P; WHYTE B; BURKE WJ; GARRICK R; O'SULLIVAN D; PENNY R; COOPER DA, 1989, 'THE NEUROLOGICAL FEATURES OF EARLY AND ‘LATENT’ HUMAN IMMUNODEFICIENCY VIRUS INFECTION', Australian and New Zealand Journal of Medicine, vol. 19, pp. 700 - 705, http://dx.doi.org/10.1111/j.1445-5994.1989.tb00339.x

Brew BJ, 1989, 'Acute encephalopathy caused by human immunodeficiency virus apparently responsive to zidovudine', Medical Journal of Australia, vol. 151, pp. 725 - 726, http://dx.doi.org/10.5694/j.1326-5377.1989.tb139683.x

Rosenblum M; Scheck AC; Cronin K; Brew BJ; Khan A; Pau M; Price RW, 1989, 'Dissociation of AIDS-related vacuolar myelopathy and productive HIV-1 infection of the spinal cord', Neurology, vol. 39, pp. 892 - 896, http://dx.doi.org/10.1212/wnl.39.7.892

Brew BJ; Hardy W; Zuckerman E; Chien N; Paul M; Rosenblum M; Gadler H; Vahlne A; Gold J; Armstrong DA; Price RW, 1989, 'AIDS‐related vacuolar myelopathy is not associated with coinfection by human T‐lymphotropic virus Type I', Annals of Neurology, vol. 26, pp. 679 - 681, http://dx.doi.org/10.1002/ana.410260515

Brew BJ; Bhalla RB; Fleisher M; Paul M; Khan A; Schwartz MK; Price RW, 1989, 'Cerebrospinal fluid β2microglobulin in patients infected with human immunodeficiency virus', Neurology, vol. 39, pp. 830 - 834, http://dx.doi.org/10.1212/wnl.39.6.830

ROSENBLUM M; SCHECK A; CRONIN K; KHAN A; PAUL M; BREW B; PRICE RW, 1989, 'DISSOCIATION OF VACUOLAR MYELOPATHY AND DETECTABLE HIV-1 INFECTION OF THE SPINAL-CORD', LABORATORY INVESTIGATION, vol. 60, pp. A80 - A80, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1989R895900485&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Brew BJ; Rosenblum M; Price RW, 1988, 'Pathogenetic implications of neuropathological findings in the AIDS dementia complex', Psychopharmacology Bulletin, vol. 24, pp. 307 - 310

Price RW; Brew B, 1988, 'Management of the neurologic complications of HIV infection and AIDS.', Infectious disease clinics of North America, vol. 2, pp. 359 - 372

Brew BJ; Price RW, 1988, 'Another Retroviral Disease of the Nervous System', New England Journal of Medicine, vol. 318, pp. 1195 - 1197, http://dx.doi.org/10.1056/NEJM198805053181809

HOUANG MTW; STERN M; BREW B; PELL M; DARVENIZA P, 1988, 'Magnetic Resonance Imaging (MRI) Appearances of Syringohydromyelia', Australasian Radiology, vol. 32, pp. 172 - 177, http://dx.doi.org/10.1111/j.1440-1673.1988.tb02717.x

Brew BJ; Rosenblum M; Price RW, 1988, 'AIDS dementia complex and primary HIV brain infection', Journal of Neuroimmunology, vol. 20, pp. 133 - 140, http://dx.doi.org/10.1016/0165-5728(88)90144-0

PRICE RW; BREW B, 1988, 'Infection of the Central Nervous System by Human Immunodeficiency Virus Role of the Immune System in Pathogenesis', Annals of the New York Academy of Sciences, vol. 540, pp. 162 - 175, http://dx.doi.org/10.1111/j.1749-6632.1988.tb27059.x

Aronow HA; Brew BJ; Price RW, 1988, 'The management of the neurological complications of HIV infection and AIDS', AIDS, vol. 2, http://dx.doi.org/10.1097/00002030-198800001-00023

Price RW; Brew BJ, 1988, 'The aids dementia complex', Journal of Infectious Diseases, vol. 158, pp. 1079 - 1083, http://dx.doi.org/10.1093/infdis/158.5.1079

HOUANG MTW; STERN M; BREW B; PELL M; SHEEHY J, 1988, 'Magnetic Resonance Imaging (MRI) of Pseudosyrinxes', Australasian Radiology, vol. 32, pp. 178 - 183, http://dx.doi.org/10.1111/j.1440-1673.1988.tb02718.x

Brew BJ; Sidtis JJ; Rosenblum M; Price RW, 1988, 'AIDS dementia complex', Journal of the Royal College of Physicians of London, vol. 22, pp. 140 - 144

Price RW; Brew B; Sidtis J; Rosenblum M; Scheck AC; Cleary P, 1988, 'The brain in AIDS: Central nervous system HIV-1 infection and AIDS dementia complex', Science, vol. 239, pp. 586 - 592, http://dx.doi.org/10.1126/science.3277272

Brew BJ; O'Sullivan DJ; Darveniza P; Selby G; Fryer J; Evans W, 1987, 'Neoplastic angioendotheliosis.', Clinical and experimental neurology, vol. 23, pp. 119 - 126

Brew BJ; Garrick R; Connelley TJ, 1987, 'Lumboperitoneal shunting as a cause of visual loss in benign intracranial hypertension.', Clinical and experimental neurology, vol. 23, pp. 233 - 235

Brew BJ; Garrick R, 1987, 'Gliomas presenting outside the central nervous system.', Clinical and experimental neurology, vol. 23, pp. 111 - 117

BREW BJ, 1986, 'DIAGNOSIS OF WERNICKE'S ENCEPHALOPATHY', Australian and New Zealand Journal of Medicine, vol. 16, pp. 676 - 678, http://dx.doi.org/10.1111/j.1445-5994.1986.tb00011.x

Tuck RR; Brew BJ; Britton AM; Loewy J, 1984, 'Alcohol and Brain Damage', British Journal of Addiction, vol. 79, pp. 251 - 259, http://dx.doi.org/10.1111/j.1360-0443.1984.tb00273.x

Darley DR; Dore GJ; Byrne A; Plit M; Brew BJ; Kelleher A; Matthews GV, 'Limited recovery from post-acute sequelae of SARS-CoV-2 (PASC) at eight months in a prospective cohort', , http://dx.doi.org/10.1101/2021.03.29.21254211

Zhang X; Chaganti J; Brew B, 2021, '034 MR spectroscopy and dynamic contrast-enhanced perfusion studies in two SARS-CoV-2 infection patients with neurological complications and no other MR abnormalities', in Oral abstracts, BMJ Publishing Group Ltd, presented at ANZAN Annual Scientific Meeting 2021 Abstracts, http://dx.doi.org/10.1136/bmjno-2021-anzan.34

Chatterton S; Dwyer L; Thomson C; Brew BJ, 2021, '088 Atypical presentations and course of JC virus infection', in Poster abstracts, BMJ Publishing Group Ltd, presented at ANZAN Annual Scientific Meeting 2021 Abstracts, http://dx.doi.org/10.1136/bmjno-2021-anzan.88

Tun NY; Chaganti J; Zeng G; Lockart I; Montagnese S; Brew B; Danta M, 2020, 'Prospective study of magnetic resonance spectroscopy identifies specific metabolite changes in covert hepatic encephalopathy', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 65 - 66, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000589476200093&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lovelace MD; Sardesai VS; Varney B; Walters E; Suzuki K; Walker D; Jones SP; Taylor R; Croitoru-Lamoury J; Lamoury FMJ; Brew BJ, 2019, 'The kynurenine pathway of tryptophan metabolism modulates mouse neural stem cell proliferation', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, Melbourne, AUSTRALIA, pp. NP3 - NP4, presented at Conference of MS-Research-Australia, Melbourne, AUSTRALIA, 31 October 2019 - 01 November 2019, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000524556200028&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Belic NK; Lovelace MD; Sardesai VS; Lim CK; Ayeni F; Padula MP; Guillemin GJ; Brew BJ, 2019, 'The kynurenine pathway of tryptophan metabolism is induced by interferon-gamma in human adipose stem cells', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, Melbourne, AUSTRALIA, pp. NP35 - NP35, presented at Conference of MS-Research-Australia, Melbourne, AUSTRALIA, 31 October 2019 - 01 November 2019, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000524556200103&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Brew B; Lehto K; Pedersen N; Lu Y; Almqvist C, 2019, 'Asthma and affective traits in adults: a genetically informative study', in EUROPEAN RESPIRATORY JOURNAL, EUROPEAN RESPIRATORY SOC JOURNALS LTD, Madrid, SPAIN, presented at European-Respiratory-Society (ERS) International Congress, Madrid, SPAIN, 28 September 2019 - 02 October 2019, http://dx.doi.org/10.1183/13993003.congress-2019.PA2774

Osvald EC; Bower H; Lundholm C; Larsson H; Brew BK; Almqvist C, 2019, 'Asthma and all-cause mortality in children and young adults - a Swedish population based study', in EUROPEAN RESPIRATORY JOURNAL, EUROPEAN RESPIRATORY SOC JOURNALS LTD, Madrid, SPAIN, presented at European-Respiratory-Society (ERS) International Congress, Madrid, SPAIN, 28 September 2019 - 02 October 2019, http://dx.doi.org/10.1183/13993003.congress-2019.OA4972

Nir TM; Lam HY; Ananworanich J; Boban J; Brew BJ; Cysique L; Fouche JP; Kuhn T; Porges ES; Law M; Paul RH; Thames A; Woods AJ; Valcour VG; Thompson PM; Cohen RA; Stein DJ; Jahanshad N, 2019, 'Effects of Diffusion MRI Model and Harmonization on the Consistency of Findings in an International Multi-cohort HIV Neuroimaging Study', in Mathematics and Visualization, pp. 203 - 215, http://dx.doi.org/10.1007/978-3-030-05831-9_17

Brew B; Almqvist C; Lundholm C; Shaheen S, 2018, 'Prescribed analgesics in pregnancy and the risk of child asthma- a register-based study.', in EUROPEAN RESPIRATORY JOURNAL, EUROPEAN RESPIRATORY SOC JOURNALS LTD, Paris, FRANCE, presented at 28th International Congress of the European-Respiratory-Society (ERS), Paris, FRANCE, 15 September 2018 - 19 September 2018, http://dx.doi.org/10.1183/13993003.congress-2018.OA3305

Brew B; Chiesa F; Lundholm C; Almqvist C, 2018, 'Combining supervised and unsupervised models to characterize asthma phenotypes in children', in EUROPEAN RESPIRATORY JOURNAL, EUROPEAN RESPIRATORY SOC JOURNALS LTD, Paris, FRANCE, presented at 28th International Congress of the European-Respiratory-Society (ERS), Paris, FRANCE, 15 September 2018 - 19 September 2018, http://dx.doi.org/10.1183/13993003.congress-2018.PA4684

Brew BK; Soderberg J; Lundholm C; Holmberg K; Almqvist C, 2018, 'Academic achievement of adolescents with asthma and atopic diseases', in ALLERGY, WILEY, Munich, GERMANY, pp. 313 - 313, presented at Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), Munich, GERMANY, 26 May 2018 - 30 May 2018, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000441690401353&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Brew B; Gong T; Lundholm C; Larsson H; Almqvist C, 2017, 'Is there a genetic association between atopic disease and internalizing disorders in children?', in EUROPEAN RESPIRATORY JOURNAL, EUROPEAN RESPIRATORY SOC JOURNALS LTD, Milan, ITALY, presented at European-Respiratory-Society (ERS) International Congress, Milan, ITALY, 09 September 2017 - 13 September 2017, http://dx.doi.org/10.1183/1393003.congress-2017.OA503

Brew B; Lundholm C; Viktorin A; Almqvist C, 2016, 'LATE-BREAKING ABSTRACT: Maternal distress and childhood asthma. A Swedish registry study', in EUROPEAN RESPIRATORY JOURNAL, EUROPEAN RESPIRATORY SOC JOURNALS LTD, http://dx.doi.org/10.1183/13993003.congress-2016.PA3137

Cysique LA; Juge L; Brew BJ; Rae C, 2015, 'DECREASED CELLULAR ENERGY IN THE BRAIN FRONTAL WHITE MATTER IS ASSOCIATED WITH PAST IMMUNOSUPPRESION IN CHRONIC HIV INFECTION', in SEXUALLY TRANSMITTED INFECTIONS, BMJ PUBLISHING GROUP, pp. A73 - A74, http://dx.doi.org/10.1136/sextrans-2015-052270.196

Adams S; Teo C; McDonald KL; Zinger A; Bustamante S; Lim CK; Sundaram G; Braidy N; Brew BJ; Guillemin GJ, 2014, 'Involvement of the kynurenine pathway in human glioma pathophysiology', in PLoS ONE, http://dx.doi.org/10.1371/journal.pone.0112945

Lim CK; Sundaram G; Brew BJ; Guillemin GJ, 2013, 'Preventing Quinolinic Acid-Induced Toxicity in Oligodendrocytes with Antagonizing Monoclonal Antibodies and Kynurenine Pathway Inhibitors', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, Kyoto, JAPAN, pp. 959 - 960, presented at 6th Congress of the Pan-Asian-Committee-on-Treatment-and-Research-in-Multiple-Sclerosis (PACTRIMS), Kyoto, JAPAN, 06 November 2013 - 08 November 2013, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000337854400200&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lu G; Brew B; Siefried K; Draper B; Cysique L, 2013, 'Moderate neurocognitive decline can be detected over a four-month period using the HIV-dementia scale', in JOURNAL OF NEUROVIROLOGY, SPRINGER, Washington, DC, pp. S51 - S51, presented at 12th International Symposium on NeuroVirology, Washington, DC, 29 October 2013 - 02 November 2013, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000325777200107&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lim CK; Stankovic RK; Wu W; Adams S; Brew BJ; Guillemin GJ, 2011, 'Involvement of the Kynurenine Pathway in Multiple Sclerosis Progression: the Link between Neuroinflammation and Neurodegeneration', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, Singapore, SINGAPORE, pp. 534 - 535, presented at 4th Congress of Pan-Asian Committee for Treatment and Research in Multiple Sclerosis (PACTRIMS), Singapore, SINGAPORE, 28 August 2011 - 30 August 2011, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000302289900095&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Sundaram G; Lim CK; Brew BJ; Guillemin GJ, 2011, 'Potential Activity of Kynurenine Pathway Modulators for Multiple Sclerosis Targeted Therapeutics', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, Singapore, SINGAPORE, pp. 535 - 535, presented at 4th Congress of Pan-Asian Committee for Treatment and Research in Multiple Sclerosis (PACTRIMS), Singapore, SINGAPORE, 28 August 2011 - 30 August 2011, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000302289900096&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Clifford D; Nath A; Cinque P; Brew BJ; Workman A; Gorelik L; Zhao J; Duda P, 2011, 'Mefloquine Treatment in Patients with Progressive Multifocal Leukoencephalopathy (PML)', in NEUROLOGY, LIPPINCOTT WILLIAMS & WILKINS, Honolulu, HI, pp. A28 - A28, presented at 63rd AAN Annual Meeting, Honolulu, HI, 09 April 2011 - 16 April 2011, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000288149300095&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Cysique LA; Myung-Lee J; Lane T; Moffat K; Davies N; Carr A; Brew BJ; Rae C, 2010, 'Glutamate excitotoxicity, cortical and subcortical neuronal damage as potential markers of HIV-associated neurocognitive disorder (HAND): A 1H-MRS and neuropsychological study', in JOURNAL OF NEUROVIROLOGY, TAYLOR & FRANCIS INC, Milan, ITALY, pp. 22 - 23, presented at 10th International Symposium on NeuroVirology, Milan, ITALY, 12 October 2010 - 16 October 2010, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000283409800048&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kandanearatchi A; Wilkinson J; Seddiki N; Zaunders J; Cunningham A; Brew BJ, 2010, 'Neurotropic HIV-1 viruses induce the Kynurenine Pathway (KP) more effectively compared to non-neurotropic viruses in monocyte derived dendritic cells (MDDCs)', in JOURNAL OF NEUROVIROLOGY, TAYLOR & FRANCIS INC, Milan, ITALY, pp. 43 - 43, presented at 10th International Symposium on NeuroVirology, Milan, ITALY, 12 October 2010 - 16 October 2010, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000283409800094&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Cysique LA; Moffat K; Fox E; Brew BJ; Rae CD, 2010, 'Frontal white matter and Posterior Cingulate abnormalities metabolite abnormalities in older and clinically stable HIV+ individuals', in Small D (ed.), Australian Neurosciences Society Annual Scientific Meeting 2010, ANS, Sydney, pp. 67 - 67, presented at Australian Neurosciences Society Annual Scientific Meeting 2010, Sydney, 31 January 2010 - 03 February 2010

Tisch S; Brew BJ, 2009, 'Parkinsonism in HIV-infected patients on highly active antiretroviral therapy', in MOVEMENT DISORDERS, WILEY-LISS, Paris, FRANCE, pp. S425 - S425, presented at 13th International Congress of Parkinsons Disease and Movement Disorders, Paris, FRANCE, 07 June 2009 - 11 June 2009, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000266618101505&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Cysique LA; Brew BJ, 2009, 'HIV-associated neurocognitive impairment in the context undetectable plasma viral load', in JOURNAL OF NEUROVIROLOGY, TAYLOR & FRANCIS INC, Miami Beach, FL, pp. 19 - 19, presented at 9th International Symposium on NeuroVirology, Miami Beach, FL, 02 June 2009 - 06 June 2009, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270278700043&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Cysique LA; Maruff P; Wright E; Brew BJ, 2009, 'The effect of age in HIV-associated neurocognitive impairment before and after the era of combination therapy', in JOURNAL OF NEUROVIROLOGY, TAYLOR & FRANCIS INC, Miami Beach, FL, pp. 19 - 20, presented at 9th International Symposium on NeuroVirology, Miami Beach, FL, 02 June 2009 - 06 June 2009, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270278700044&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Pemberton LA; Thompson K; Churchill M; Guillemin G; Gorry PR; Wesselingh S; Brew BJ, 2009, 'Mechanism for involvement of S-100 beta in HIV associated dementia', in JOURNAL OF NEUROVIROLOGY, TAYLOR & FRANCIS INC, Miami Beach, FL, pp. 72 - 72, presented at 9th International Symposium on NeuroVirology, Miami Beach, FL, 02 June 2009 - 06 June 2009, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270278700149&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Gray LR; Roche M; Churchill MJ; Sterjovski J; Ellett A; Poumbourios P; Sherrief S; Wang B; Saksena N; Purcell DFJ; Wesselingh S; Cunningham AL; Brew BJ; Gabuzda D; Gorry PR, 2009, 'Tissue-specific sequence alterations in the HIV-1 envelope favoring CCR5-usage contribute to persistence of dual-tropic virus in brain', in JOURNAL OF NEUROVIROLOGY, TAYLOR & FRANCIS INC, Miami Beach, FL, pp. 31 - 32, presented at 9th International Symposium on NeuroVirology, Miami Beach, FL, 02 June 2009 - 06 June 2009, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270278700068&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Pemberton LA; Sterjovski J; Ramsland P; Gorry PR; Brew BJ, 2009, 'Altered Structural Conformation of the V3 Region between CSF Isolates from HAD and Non-HAD Individuals: Implications for Co-Receptor Usage', in JOURNAL OF NEUROVIROLOGY, TAYLOR & FRANCIS INC, Miami Beach, FL, pp. 71 - 72, presented at 9th International Symposium on NeuroVirology, Miami Beach, FL, 02 June 2009 - 06 June 2009, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270278700148&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Cysique LA; Brew BJ, 2009, 'HIV-associated neurocognitive impairment in the context undetectable plasma viral load', in Journal of Neurovirology, Taylor & Francis Inc, Philadelphia, PA, USA, pp. P42 - P42

Clifford D; Brew BJ; Cinque P; Gorelik L; Bennett D; Panzara M; Duda P; Nath A, 2009, 'Design of a clinical trial of mefloquine in patients with progressive multifocal leukoencephalopathy', in Multiple Sclerosis, Arnold, London, England, pp. S87 - S87, presented at 25th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis, Dusseldorf, GERMANY, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000269652500255&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Guillemin GJ; Cullen KM; Smythe GA; Lim CK; Garner B; Brew BJ, 2008, 'Characterization of the kynurenine pathway in human primary neurons', in Proceedings of Aust Neuroscience Society, Australian Neuroscience Society 28th Annual Meeting, Hobart, pp. 78 - 78, presented at Australian Neuroscience Society 28th Annual Meeting, Hobart, 27 January 2008 - 30 January 2008

Cysique LA; Maruff P; Wright E; Brew BJ, 2008, 'The effect of age in HIV-associated neurocognitive impairment before and after the era of combination therapy', in Journal of Neurovirology, Taylor & Francis Inc, Philadelphia, PA, USA, pp. P43 - P43, presented at Petrophysics

Kandanearatchi A; Guillemin G; Wilkinson J; Cunningham A; Brew B, 2007, 'The kynurenine pathway metabolite quinolinic acid upregulates CCR5 expression', in JOURNAL OF NEUROVIROLOGY, TAYLOR & FRANCIS INC, San Diego, CA, pp. 91 - 91, presented at 8th International Symposium on Neurovirology, San Diego, CA, 30 October 2007 - 02 November 2007, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000250754000172&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Cinque P; Sidenius N; Bestetti A; Sala S; Lazzarin A; Brew BJ; Gisslen M-N; Hagberg L; Price RW, 2007, 'Cerebrospinal fluid (CSF) soluble urokinase plasminogen activator (uPA) receptor (suPAR) in AIDS dementia complex, and its relationships with other uPA, virological, immuneactivation and neuronal CSF markers', in JOURNAL OF NEUROVIROLOGY, TAYLOR & FRANCIS INC, San Diego, CA, pp. 6 - 6, presented at 8th International Symposium on Neurovirology, San Diego, CA, 30 October 2007 - 02 November 2007, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000250754000009&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Brew BJ; Pemberton L; Thompson K; Gorry P; Wesselingh S, 2007, 'S-100b: Role in the pathogenesis of HIV associated dementia (HAD)', in NEUROLOGY, LIPPINCOTT WILLIAMS & WILKINS, Boston, MA, pp. A140 - A140, presented at 59th Annual Meeting of the American-Academy-of-Neurology, Boston, MA, 28 April 2007 - 05 May 2007, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000245175001043&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Brew BJ; Cysique LA; Maruff P, 2006, 'Variable benefit in neuropsychological function in HIV infected HAART-treated patients', in NEUROLOGY, LIPPINCOTT WILLIAMS & WILKINS, San Diego, CA, pp. A257 - A257, presented at 58th Annual Meeting of the American-Academy-of-Neurology, San Diego, CA, 01 April 2006 - 08 April 2006, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000236068103065&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Johnson DW; Brew BK; Poronnik P; Cook DI; Field MJ; Gyory AZ; Pollock CA, 1997, 'Insulin-like growth factor-1 (IGF-I) stimulates apical sodium-hydrogen exchange (NHE) in human proximal tubule cells (PTC).', in KIDNEY INTERNATIONAL, BLACKWELL SCIENCE INC, pp. 1323 - 1323, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1997WP69600120&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Johnson DW; Brew BK; Poronnik P; Cook DI; Field MJ; Pollock CA, 1997, 'Transport characteristics of human proximal tubule cells (PTC) in primary culture.', in KIDNEY INTERNATIONAL, BLACKWELL SCIENCE INC, pp. 1306 - 1306, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1997WP69600045&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Johnson DW; Brew BK; Field MJ; Gyory AZ; Pollock CA, 1997, 'Evidence for a paracrine growth-regulatory loop involving proximal tubule epithelial cells and cortical fibroblasts in the human kidney.', in KIDNEY INTERNATIONAL, BLACKWELL SCIENCE INC, pp. 1307 - 1307, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1997WP69600048&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Brew BJ, 1997, 'AIDS dementia complex and its prevention', in Antiviral Therapy, Int Medical Press Ltd, London, England, pp. 69 - 73, presented at ZERIT in the management of HIV disease, Cannes, France, 22 March 1997

Brew BJ; Dunbar N; Pemberton LA; Kaldor JM, 1995, 'Predictive markers of AIDS dementia complex: CD4 cell count and cerebrospinal fluid concentrations of B2microglobulin and neopterin', in Journal of Infectious Diseases, University of Chicago Press, Chicago, IL, pp. 294 - 298, presented at International Conference on AIDS in Asia and the Pacific, Chang Mai, Thailand, 17 September 1995 - 21 September 1995, http://dx.doi.org/10.1093/infdis/174.2.294

Brew BJ, 1993, 'HIV-1-related neurological disease', in Journal of Acquired Immune Deficiency Syndromes, pp. S10 - S15

Sweeney JA; Brew BJ; Keilp JG; Sidtis JJ; Price RW, 1991, 'Pursuit eye movement dysfunction in HIV-1 seropositive individuals.', in Journal of psychiatry & neuroscience : JPN, pp. 247 - 252

HEYES MP; BREW BJ; PRICE RW; MARKEY SP, 1989, 'CEREBROSPINAL-FLUID QUINOLINIC ACID AND KYNURENIC ACID IN HIV-1 INFECTION', in GUIDOTTI A (ed.), NEUROTOXICITY OF EXCITATORY AMINO ACIDS, RAVEN PRESS, SCOTTSDALE, AZ, pp. 217 - 221, presented at SYMP ON NEUROTOXICITY OF EXCITATORY AMINO ACIDS, SCOTTSDALE, AZ, 26 October 1989 - 28 October 1989, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1990BS78Z00017&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Cysique L; Juge L; Lennon M; Gates T; Jones S; Lovelace M; Rae C; Johnson T; Nath A; Brew B, 2018, 'HIV Brain Latency May Directly Suppress Brain Cellular Energy', in JOURNAL OF NEUROVIROLOGY, SPRINGER, Chicago, IL, Vol. 24, pp. S19 - S19, presented at Joint Meeting of the International-Society-for-NeuroVirology (ISNV) and the Society-on-NeuroImmune-Pharmacology (SNIP), Chicago, IL, 10 April 2018 - 14 April 2018, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000434755400066&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Asahchop E; Branton W; Zochodne D; Brew B; Gill J; Power C, 2018, 'microRNA-455-3p predicts HIV-associated symptomatic distal sensory polyneuropathy and suppresses NGF expression in human neurons', in JOURNAL OF NEUROVIROLOGY, SPRINGER, Chicago, IL, Vol. 24, pp. S2 - S2, presented at Joint Meeting of the International-Society-for-NeuroVirology (ISNV) and the Society-on-NeuroImmune-Pharmacology (SNIP), Chicago, IL, 10 April 2018 - 14 April 2018, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000434755400007&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Asahchop E; Branton W; Zochodne D; Brew B; Gill J; Power C, 2018, 'microRNA-455-3p predicts HIV-associated symptomatic distal sensory polyneuropathy and suppresses NGF expression in human neurons', in JOURNAL OF NEUROIMMUNE PHARMACOLOGY, SPRINGER, Vol. 13, pp. S2 - S2, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000429149100007&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lovelace M; Croitoru-Lamoury J; Lamoury FMJ; Walters E; Suzuki K; Walker D; Jones SP; Taylor R; Brew BJ, 2017, 'The kynurenine pathway of tryptophan metabolism modulates neural stem cell proliferation', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, MS Res Australia, Sydney, AUSTRALIA, Vol. 23, pp. NP27 - NP27, presented at Progress in MS Research Conference, MS Res Australia, Sydney, AUSTRALIA, 11 October 2017 - 13 October 2017, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000414783200074&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lovelace M; Sardesai V; Varney B; Guillemin GJ; Brew BJ, 2017, 'Laquinimod as a regulator of Kynurenine Pathway in Multiple Sclerosis', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, MS Res Australia, Sydney, AUSTRALIA, Vol. 23, pp. NP27 - NP27, presented at Progress in MS Research Conference, MS Res Australia, Sydney, AUSTRALIA, 11 October 2017 - 13 October 2017, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000414783200073&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Gott C; Gates T; Dermody N; Brew B; Cysique L, 2016, 'Cognitive Change Trajectories in Virally Suppressed HIV-Infected Individuals Suggest High Prevalence of Ongoing Disease Activity', in JOURNAL OF NEUROVIROLOGY, SPRINGER, Toronto, CANADA, Vol. 22, pp. S24 - S25, presented at 14th International Symposium on NeuroVirology, Toronto, CANADA, 25 October 2016 - 28 October 2016, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000394093700051&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Brew BJ; Faux S; Blanchard E, Efficacy of a smartwatch application in detecting induced falls (Preprint), http://dx.doi.org/10.2196/preprints.30121